Document:

EX-10.36

 Exhibit 10.36 

SEATGEEK, INC. 

902 Broadway, 10th Floor 
 New York,
NY 10010 
 October 4, 2021 
 Carolyn
Patterson 
 By email 
 Dear Carolyn: 

This letter (the “Agreement”) confirms the agreement between you and SeatGeek, Inc. (the
“Company”) with respect to certain matters concerning your continued employment with the Company, and hereby amends, restates, replaces and supersedes your employment offer letter with the Company (the “Offer
Letter”). 
 Position and Responsibilities 

You will continue to serve as the Company’s Chief People Officer. In your employment position, you will report solely and directly to the
Company’s Chief Executive Officer (the “CEO”). In this capacity, you will serve and will be responsible for such duties and have such authorities as are normally associated with such position or as may otherwise be
reasonably determined by the CEO consistent with such position. Your specific duties and responsibilities may change from time to time as determined by the needs of the Company and the policies established by the Company; provided that such duties
and responsibilities and your authorities remain consistent with your position as Chief People Officer. While reasonable travel in the performance of your duties may be required, you will work principally from a home office in San Francisco, CA.

 Compensation and Benefits 
 You will
continue to be paid a base annual salary at the rate of $350,000 per year, less payroll deductions and all required withholdings, subject to potential increase but not decrease (the “Base Salary”). You will be paid the base
salary in accordance with the Company’s standard payroll practices, and you will be eligible for standard benefits, such as medical insurance, paid time off, and holidays, according to standard Company policy as may be adopted by the Company
from time to time. 
 In addition to your base salary, you will be eligible to receive performance-based bonuses based on achievement of
Company, division and/or individual performance goals to be set by the CEO and/or the Board. Your target annual bonus will be forty three percent (43%) of your Base Salary, less payroll deductions and all required withholdings. Performance-based
bonuses are currently paid semi-annually. For the period July 1, 2021 to December 31, 2021, you will be eligible to receive a performance-based bonus with any amounts earned prorated based on the number of days that you were employed by
the Company during such period. Unless otherwise agreed in writing pursuant to a bonus plan or bonus agreement approved by the CEO and/or the Board, bonus payments, if any, are not guaranteed and will be awarded based upon achievement of performance
goals established in writing by the Compensation Committee of the Board in consultation with the Chief Executive Officer and communicated to you. Except as provided under the heading “Severance Benefits” below, to be eligible for a
performance bonus, you must maintain full time employment status at the time of the payment and no portion of a performance bonus is earned until paid. The Company may change its employee compensation and benefits plans and programs from time to
time at its discretion. 
 Subject to approval of the Company’s Board of Directors (the “Board”) (or committee
thereof), you will be granted an award of restricted stock units with respect to 500,000 shares of Common Stock of the Company (the “RSU Award”). The RSU Award will be granted under, and be subject to, the terms and
conditions of the Company’s applicable equity incentive plan in place as of the date of grant of the RSU Award (the “Plan”) and the Company’s form of RSU award agreement thereunder. The RSU Award will be subject to
both a service-based vesting condition lapsing over 4 years (25% of the RSU Award vesting after 12 months of continued employment from your employment commencement date and the remainder of the RSU Award vesting quarterly in equal amounts over the
next 3 years), 

  
 1 

 
and a liquidity event-based vesting condition, both of which must be satisfied in order to vest and if your service with the Company terminates prior to satisfaction of the liquidity event
condition, the RSU Award shall be forfeited. For the avoidance of doubt, the RSU Award shall supersede and replace the New Option described in your Offer Letter and you shall not be entitled to receive the New Option. 

You will be eligible to participate in all long-term cash and equity incentive plans, practices, policies and programs generally applicable to
other similarly situated senior executives of the Company, and you will be considered for annual equity awards as may be determined by the Compensation Committee of the Board in its discretion, taking into consideration similar equity grants to
similarly situated executives at similarly situated companies and other factors that the Compensation Committee deems relevant, with a vesting schedule and other terms and conditions consistent with those applicable generally to grants to other
senior officers, in accordance with the terms of any applicable equity plan or arrangement that may be in effect from time to time. 
 Severance Benefits

 If (x) the Company terminates your employment for any reason other than for Cause (as defined below), death or Disability (as
defined below), or (y) you resign from your employment with the Company for Good Reason (as defined below) (each such event, a “Qualified Separation”), subject to the terms of this Agreement (including satisfaction of
the Release Requirement) and your continued compliance in all material respects with your Non-Disclosure and Non-Compete Agreement (which noncompliance, if curable in
the reasonable discretion of the Company, is not cured to the reasonable satisfaction of the Company within thirty (30) days after receipt of written notice from the Company of such noncompliance), then the Company shall pay or provide you with
the following benefits: (i) severance payments in the form of salary continuation at a rate equal to your Base Salary, at the rate in effect at the time of your separation date (and prior to any reduction that would constitute Good Reason
hereunder), for the Severance Period; (ii) a pro-rata portion (based upon the number of days you were employed in the applicable year) of your annual bonus target for the year in which your termination
occurs (iii) provided you timely elects continued coverage under COBRA, or state continuation coverage (as applicable), under the Company’s group health plans following such termination, the Company will pay the full COBRA, or state
continuation coverage, premiums to continue your (and your covered dependents, as applicable) health insurance coverage in effect on the termination date until the earliest of: (1) the last day of the final full month of the Severance Period;
(2) the date when you become eligible for substantially equivalent health insurance coverage in connection with new employment or self-employment; or (3) the date you cease to be eligible for COBRA or state law continuation coverage for
any reason, including plan termination; provided that if at any time the Company determines that its payment of COBRA, or state continuation coverage, premiums on your behalf would result in a violation of applicable law (including, but not limited
to, the 2010 Patient Protection and Affordable Care Act, as amended by the 2010 Health Care and Education Reconciliation Act), then in lieu of paying such premiums pursuant to this Section, the Company shall pay you on the last day of each remaining
month of the period specified above, a fully taxable cash payment equal to the COBRA or state continuation coverage premium for such month, subject to applicable tax withholding, for the remainder of such period; and (iv) unless an option award
provides for a more favorable post-termination exercise period, with respect to any options granted to you, such options (to the extent that you are entitled to exercise such options as of the date of termination of continuous service) shall be
exercisable until the date that is six (6) months after the termination of your employment with the Company (whether voluntary or involuntary), subject to earlier termination in accordance with the Plan, and in no event will your options be
exercisable beyond the original expiration date of such options. In addition, the Company shall pay or provide you with the following: (i) any unpaid accrued bonus for the immediately prior year (payable when bonuses are paid to other
executives of the Company), (ii) any unpaid accrued vacation in accordance with the Company’s paid time off policies, (iii) unreimbursed expenses (paid pursuant to the Company’s expense reimbursement policy) and (iv) all accrued
vested benefits provided pursuant to the terms of the Company’s benefit plans (the “Accrued Obligations”). Your right to receive your severance amounts shall not be subject to mitigation or reduced by any other amounts you receive
from a subsequent employer or otherwise except as provided under clause (2) of the COBRA reimbursement provisions set forth above. 

In addition, if a Change in Control (as defined below) is consummated and a Qualified Separation occurs within the Change in Control Period,
then (i) 100% of the then-unvested portion of any stock option or restricted stock award issued to you by the Company shall vest as of the Release Effective Date, (ii) unless an option award provides for a more favorable post-termination
exercise period, with respect to any options granted to you, such options shall be exercisable until the date that is eighteen (18) months after the termination of your employment with the Company

  
 2 

 
(whether voluntary or involuntary), subject to earlier termination in accordance with the Plan, and in no event will your options be exercisable beyond the original expiration date of such
options and (iii) provided such transaction constitutes a change in the ownership or effective control of the Company or a change in the ownership of a substantial portion of the Company’s assets within the meaning of Section 409A of
the Code, the cash severance payments described in clause (i) of the preceding paragraph will be paid in a single lump sum on the first payroll date that follows the Release Effective Date. Notwithstanding the foregoing, if such termination
occurs during the Change in Control Period, but prior to a Change in Control, cash severance shall commence to be paid in installments in accordance with clause (i) of the preceding paragraph, and upon the occurrence of such Change in Control,
the remainder of the cash severance payment shall be payable in a lump-sum in accordance with this section on the first regular payroll date following the closing of such Change in Control. 

The severance payments described above will be paid in accordance with the Company’s standard payroll procedures, and, subject to your
satisfaction of the Release Requirement (as defined below), will commence on the first payroll date that follows the Release Effective Date, and once they commence will be retroactive to the date of your Qualified Separation. The pro-rata portion of your bonus will be paid within seven business days following the Release Effective Date. 

You will not be entitled to any of the benefits described above unless you (i) have returned all Company property in your possession,
including (without limitation) copies of documents that belong to the Company and files stored on your computer(s) that contain information belonging to the Company and (ii) have satisfied the following release requirements (the
“Release Requirement”): sign and return a separation agreement and general release of claims in the form attached hereto as Exhibit A, including any reasonable modifications taking into consideration relevant federal
and state laws at the time of termination (the “Release”) and such Release becomes effective and irrevocable no later than sixty (60) days following the date of your Qualified Separation or such earlier date required by
the release (the “Release Deadline”), and permit the Release to become effective and irrevocable in accordance with its terms (such effective date of the Release, the “Release Effective Date”). If you
fail to return the release on or before the Release Deadline, or if you revoke the release, then you will not be entitled to the benefits described above. You acknowledge and agree that if you resign without Good Reason or if the Company terminates
your employment for Cause, you will not be eligible to receive any of the benefits described above, other than the Accrued Obligations (but not including the payment under clause (i) of Accrued Obligations). 

It is intended that all of the payments and benefits payable under this Agreement satisfy, to the greatest extent possible, the exemptions
from the application of Code Section 409A and this Agreement will be construed to the greatest extent possible as consistent with those provisions, and to the extent no so exempt, this Agreement (and any definitions hereunder) will be construed
in a manner that complies with Section 409A. If the parties agree in good faith that this Agreement is not in compliance with Section 409A, the parties shall cooperate to attempt to modify this Agreement to comply with Section 409A
while endeavoring to maintain its economic benefits to the greatest extent practicable. For purposes of Code Section 409A (including, without limitation, for purposes of Treasury Regulation
Section 1.409A-2(b)(2)(iii)), your right to receive any installment payments under this Agreement (whether severance payments, reimbursements or otherwise) shall be treated as a right to receive a series
of separate payments and, accordingly, each installment payment hereunder shall at all times be considered a separate and distinct payment. Notwithstanding any provision to the contrary in this Agreement, if you are deemed by the Company at the time
of your “separation from service” (as defined under Treasury Regulation Section 1.409A-1(h), without regard to any alternative definition thereunder, a “Separation from Service”) to be
a “specified employee” for purposes of Code Section 409A(a)(2)(B)(i), and if any of the payments upon Separation from Service set forth herein and/or under any other agreement with the Company are deemed to be “deferred
compensation” for purposes of Code Section 409A, then to the extent delayed commencement of any portion of such payments is required in order to avoid a prohibited distribution under Code Section 409A(a)(2)(B)(i) and the related
adverse taxation under Section 409A, such payments shall not be provided to you prior to the earliest of (i) the expiration of the six-month and one day period measured from the date of your
Separation from Service with the Company, (ii) the date of your death or (iii) such earlier date as permitted under Section 409A without the imposition of adverse taxation. Upon the first business day following the expiration of such
applicable Code Section 409A(a)(2)(B)(i) period, all payments deferred pursuant to this Section shall be paid in a lump sum to you, and any remaining payments due shall be paid as otherwise provided herein or in the applicable agreement. No
interest shall be due on any amounts so deferred. If the Company determines that any severance benefits provided under this Agreement constitutes “deferred compensation” under Section 409A, for purposes of determining the schedule for
payment of the severance benefits, the effective date of the Release will not 

  
 3 

 
be deemed to have occurred any earlier than the sixtieth (60th) date following the Separation From Service, regardless of when the Release actually becomes effective. In addition to the above, to
the extent required to comply with Section 409A and the applicable regulations and guidance issued thereunder, if the applicable time period for you to execute (and not revoke) the applicable Release spans two calendar years, payment of the
applicable severance benefits shall not commence until the beginning of the second calendar year. The Company makes no representation that compensation paid pursuant to the terms of this Agreement will be exempt from or comply with Section 409A
and makes no undertaking to preclude Section 409A from applying to any such payment. 
 In addition, you acknowledge and agree that the
payments and benefits described in this agreement (in addition to any other payments and benefits payable to you by the Company or any affiliate thereof) may be subject to reduction as set forth on Attachment A, which is hereby incorporated
into this Agreement. 
 Definitions 

For purposes of this Agreement, the following definitions will apply: 

“Cause” shall mean: (i) your continued failure to substantially perform the material duties and obligations under
this Agreement (for reasons other than death or physical or mental infirmity and not including solely poor performance), which failure, if curable within the reasonable discretion of the Company, is not cured to the reasonable satisfaction of the
Company within thirty (30) days after receipt of written notice from the Company of such failure; (ii) your material failure or refusal to comply with the material policies, standards and regulations established in writing by the Company
from time to time which failure, if curable in the reasonable discretion of the Company, is not cured to the reasonable satisfaction of the Company within thirty (30) days after receipt of written notice of such failure from the Company;
(iii) any act of material personal dishonesty, fraud, embezzlement, material misrepresentation, or other unlawful act committed by you in connection with your employment with the Company that benefits you at the expense of the Company;
(iv) except with respect to driving violations, your conviction of, or plea of “guilty” or “no contest” to, a felony under the laws of the United States or any state; or (v) your material breach of the terms of this
Agreement or the Non-Disclosure and Non-Compete Agreement, which breach, if curable in the reasonable discretion of the Company, is not cured to the reasonable
satisfaction of the Company within thirty (30) days after receipt of written notice from the Company of such breach. No action or inaction shall constitute Cause if taken at the lawful direction of the Board or an executive officer to whom you
report. 
 “Change in Control” shall have the meaning set forth in the Plan, as amended. 

“Change in Control Period” means the time period beginning on the date that is two (2) months prior to the Change
in Control and ending on the date that is twelve (12) months following the Change in Control. 
 “Code” means
the Internal Revenue Code of 1986, as amended. 
 “Disability” shall mean any physical incapacity or mental
incompetence as a result of which you are unable to perform the essential functions of your job for an aggregate of 120 days, whether or not consecutive, during any calendar year, and which cannot be reasonably accommodated by the Company without
undue hardship. 
 “Good Reason” means resignation following the occurrence of one or more of the following, without
your express written consent, provided you have complied with the Good Reason Process described below: (i) a material reduction in your duties, position, authority or responsibilities; (ii) a reduction in your base salary or bonus
opportunity (except for reductions in compensation of less than 10% in the aggregate applicable to all similarly situated senior executives of the Company on a proportionate basis); (iii) the Company’s material breach of a material provision of
this Agreement or any other agreement with you; or (iv) a relocation of 25 or more miles from your present location (other than due to reasonable and customary business travel or requirements that you perform services remotely). You will not
resign for Good Reason unless (1) you first provide the Company with written notice of the acts or omissions constituting the grounds for “Good Reason” within 90 days of the initial existence of the grounds for “Good
Reason,” (2) you provide a reasonable cure period of not less than 30 days following the date of such notice if such act or omission is capable of cure, (3) the Company fails to cure such act or omission within such cure period and
(4) you resign with Good Reason within thirty (30) days following the conclusion of such cure period ((1) through (4), the “Good Reason Process”). 

  
 4 

 “Severance Period” means (i) if a Qualified Separation occurs
but not within the Change in Control Period of a Change in Control that is actually consummated, six months or (ii) if a Qualified Separation occurs within the Change in Control Period of a Change in Control that is actually consummated, twelve
months. 
 Company Rules and Policies 

As a Company employee, you will be expected to continue to abide by Company rules, regulations and policies. 

Normal working hours for your position are from 9am to 6pm, Monday through Friday however your working schedule shall be flexible, provided
that you are working equivalent hours, at a minimum. As an exempt salaried employee, you will be expected to work additional hours as required from time to time by the nature of your work assignments. 

Termination of Employment 
 Unless agreed
to in writing between you and the Company during the term of your employment, your employment with the Company shall be “at will”. You may terminate your employment with the Company at any time and for any reason whatsoever simply by
notifying the Company. Likewise, the Company may terminate your employment at any time and for any reason whatsoever, with or without cause or advance notice, subject to your right to receive severance and other benefits set forth herein upon
certain termination events provided herein. This at-will employment relationship cannot be changed except by a written document signed by you and a member of the Board. 

Miscellaneous 
 All payments under this
Agreement will be made net of applicable withholding taxes and other required deductions. 
 The Company shall provide you with
indemnification to the fullest extent permitted by applicable state law and coverage under directors’ and officers’ liability insurance policies to the same extent provided to other senior executives, both during your employment and
thereafter while potential liability may exist. 
 The terms in this Agreement supersede any other agreements or promises made to you by
anyone, whether verbal or written, and comprise the final, complete and exclusive agreement between you and the Company with regard to severance and the other benefits described herein. For the avoidance of doubt, the terms of the Non-Disclosure and
Non-Compete Agreement shall survive this Agreement. For further avoidance of doubt, the benefits described herein with respect to the accelerated vesting of equity upon the termination of your employment with
the Company following a Change in Control, shall supersede and replace such accelerated vesting of equity terms set forth in any stock option or restricted stock unit award agreements that you have entered into with the Company prior to the date
hereof. At all times in the future, you will remain bound by your Non-Disclosure and Non-Compete Agreement with the Company. Notwithstanding anything to the contrary
contained in this Agreement, you acknowledge that (i) you have received a one-time signing bonus of $100,000 (the “Signing Bonus”) (less required federal, state and local withholdings) on or
about July, 2021, but (ii) the Signing Bonus is not considered “earned” until July 12, 2022. You understand that by signing this Agreement you are acknowledging that the payment of this Signing Bonus was an unearned advance and
that in the event that either you resign from the Company without Good Reason or Company terminates your employment for Cause prior to July 12, 2022, you shall repay the Signing Bonus, in full, to the Company within ten (10) business days
after the termination of your employment. The terms of this letter agreement and the resolution of any disputes will be governed by California law. 

  
 5 

 Successors 

This Agreement will be binding upon and inure to the benefit of (a) your heirs, executors and legal representatives upon your death and
(b) any successor of the Company. Any such successor of the Company will be deemed substituted for the Company under the terms of this Agreement for all purposes. For this purpose, “successor” means any person, firm, corporation or
other business entity which at any time, whether by purchase, merger or otherwise, directly or indirectly acquires all or substantially all of the assets or business of the Company. None of your rights to receive any form of compensation payable
pursuant to this Agreement may be assigned or transferred except by will or the laws of descent and distribution. Any other attempted assignment, transfer, conveyance or other disposition of your right to compensation or other benefits will be null
and void. 
  

			
	Thank you for your continued contributions to SeatGeek.
	
	Very truly yours,
	
	SeatGeek, Inc.
		
	By:	 	/s/ Jon Groetzinger
		 	Jon Groetzinger
		 	Chief Executive Officer

 I have read and accept this letter: 
  

			
	/s/ Carolyn Patterson
		
	Dated:	 	10/7/21

  
 6 

 ATTACHMENT A 

In the event any payment, benefit or distribution of any type to or for the benefit of you, whether paid or payable, provided or to be
provided, or distributed or distributable pursuant to the terms of this Agreement or otherwise, constitutes a “parachute payment” under Section 280G of the Code, the amount payable to you shall be either (a) paid in full, or
(b) paid after reduction by the smallest amount as would result in no portion thereof being subject to the excise tax under Section 4999 of the Code, whichever of the foregoing amounts, taking into account the applicable federal, state and
local income taxes and the excise tax under Section 4999 of the Code, results in the receipt by you, on an after-tax basis, of the greater net value, notwithstanding that all or some portion of such
payment amount may be taxable under Section 4999 of the Code. Unless the Company and you otherwise agree in writing, all determinations required to be made under this paragraph, including the manner and amount of any reduction in your payments
hereunder, and the assumptions to be utilized in arriving at such determinations, shall be made in writing in good faith by the accounting firm serving as the Company’s independent public accounting firm immediately prior to the event giving
rise to such payment or such other nationally recognized accounting firm or advisor as the parties may mutually agree (the “Accounting Firm”); provided, however, that no such reduction or elimination shall apply to any non-qualified deferred compensation amounts (within the meaning of Section 409A of the Code) to the extent such reduction or elimination would accelerate or defer the timing of such payment in manner that does
not comply with Section 409A of the Code. For purposes of making the determinations and calculations required by this paragraph, the Accounting Firm may make reasonable assumptions and approximations concerning the application of Sections 280G
and 4999 of the Code, provided that no portion of any such amounts shall be taken into account which constitutes reasonable compensation for services actually rendered, within the meaning of Section 280G(b)(4)(B) of the Code, in excess of the
“base amount” (as set forth in Section 280G(b)(3) of the Code) that is allocable to such reasonable compensation. The Company and you shall furnish to the Accounting Firm such information and documents as the Accounting Firm may
reasonably request to make a determination under this paragraph. The Accounting Firm shall provide its written report to the Compensation Committee of the Board and you, which shall include information regarding methodology and detailed supporting
calculations. The Company shall bear all reasonable fees, costs and expenses the Accounting Firm may incur in connection with any calculations contemplated by this paragraph. You and the Company shall reasonably cooperate in case of a potential
change in control of the Company (within the meaning of Section 280G of the Code) to consider alternatives to mitigate any Section 280G exposure, including the valuation of any noncompetition covenants, although the Company cannot
guarantee any such alternatives will be available or approved by the Company and neither you nor the Company shall be obligated to enter into any alternative arrangements. 

  
 7 

 Exhibit A 

Form of Separation Agreement and General Release of Claims 

GENERAL RELEASE 

GENERAL RELEASE (the “Release”), by __________________ (the “Executive”) in favor of SeatGeek, Inc.
(the “Company”) and the Company Releasees (as hereinafter defined) Capitalized terms used herein but not specifically defined shall have the meanings set forth in the Employment Agreement between Executive and the Company, dated as
of [__], 2021 (the “Employment Agreement”). 
 WHEREAS, in connection with the termination of Executive’s
employment, the Company has agreed to provide Executive with the payments and benefits set forth in the Employment Agreement, subject to the terms and conditions set forth therein. 

NOW, THEREFORE, in consideration of the covenants and agreements hereinafter set forth, the parties agree as follows: 

1. General Release. Executive, for Executive and for Executive’s heirs, executors, administrators, successors and assigns (referred
to collectively as “Releasors”) hereby irrevocably and unconditionally, and knowingly and voluntarily, waives, terminates, cancels, releases and discharges forever the Company, and its subsidiaries, affiliates and related entities,
and any and all of their respective predecessors, successors, assigns and employee benefit plans, and, in such capacities, each of their respective owners, assigns, agents, directors, general and limited partners, shareholders, directors, officers,
employees, attorneys, trustees, fiduciaries, administrators, agents or representatives, and any of their predecessors and successors and each of their estates, heirs and assigns (collectively, the “Company Releasees”) from any and
all charges, allegations, complaints, claims, liabilities, obligations, promises, agreements, causes of action, rights, costs, losses, debts and expenses of any nature whatsoever, known or unknown, suspected or unsuspected (collectively,
“Claims”) which Executive or the Releasors ever had, now have, may have, or hereafter can, will or may have (either directly, indirectly, derivatively or in any other representative capacity) by reason of any matter, fact or cause
whatsoever against the Company or any of the other Company Releasees: from the beginning of time to the date upon which Executive signs this Release arising out of, or relating to, Executive’s employment with the Company and/or the termination
of Executive’s employment. This Release includes, without limitation, all claims for attorneys’ fees and punitive or consequential damages and all claims arising under any federal, state and/or local labor, employment, whistleblower and/or
anti-discrimination laws and/or regulations, including, without limitation, the Age Discrimination in Employment Act of 1967 (“ADEA”), Title VII of the Civil Rights Act of 1964, the Employee Retirement Income Security Act, the
Americans with Disabilities Act, the Family and Medical Leave Act, the Civil Rights Act of 1991, the Equal Pay Act, the Immigration and Reform Control Act, the Uniform Services Employment and Re-Employment
Act, the Rehabilitation Act of 1973, Executive Order 11246, the Sarbanes-Oxley Act, the Dodd-Frank Wall Street Reform and Consumer Protection Act, the Worker Adjustment Retraining and Notification Act and the Family Medical Leave Act, and any
similar state or federal statute, including all amendments to any of the aforementioned acts or under any common law or equitable theory including, but not limited to, tort, breach of contract, fraud, fraudulent inducement, promissory estoppel or
defamation, and violations of any other federal, state, or municipal fair employment statutes or laws, including, without limitation, violations of any other law, rule, regulation, or ordinance pertaining to employment, wages, compensation, hours
worked, or any other matters related in any way to the foregoing; provided, however, that nothing in this Release shall release or impair any rights that cannot be waived under applicable law. 

2. Section 1542 Waiver. In giving the release herein, which includes claims which may be unknown to you at present, Executive acknowledges that
Executive has read and understands Section 1542 of the California Civil Code, which reads as follows: 
 “A general release does
not extend to claims that the creditor or releasing party does not know or suspect to exist in his or her favor at the time of executing the release and that, if known by him or her, would have materially affected his or her settlement with the
debtor or released party.” 

  
 A-1 

 Executive hereby expressly waives and relinquishes all rights and benefits under that section and any law of
any other jurisdiction of similar effect with respect to Executive’s release of claims herein, including but not limited to Executive’s release of unknown claims. 

3. Surviving Claims. Notwithstanding anything herein to the contrary, this Release shall not: 

(a) limit or prohibit in any way Executive’s (or Executive’s beneficiaries’ or legal representatives’) rights to bring an
action to enforce the terms of the Employment Agreement or this Release; 
 (b) release any claim for employee benefits under plans covered
by the Employee Retirement Income Security Act of 1974, as amended, to the extent that such claims may not lawfully be waived, or for any payments or benefits under any benefit plans of the Company and its affiliates in which Executive was a
participant as of the date of termination of Executive’s employment that have accrued or vested in accordance with and pursuant to the terms of those plans; 

(c) release any claims in respect of Executive’s equity interests (including equity incentive awards) in the Company or its affiliates, in
each case, in accordance with their terms and any applicable plan, subscription and/or contribution agreement, award agreement, the Employment Agreement, shareholders agreement and/or corporate governance documents; or 

(d) release any claims for indemnification or recovery (i) in accordance with applicable laws or the corporate governance documents of the
Company or its affiliates in accordance with their terms as in effect from time to time, (ii) pursuant to any applicable directors and officers insurance policy with respect to any liability incurred by Executive as an officer or director of
the Company or its affiliates in accordance with the terms thereof or (iii) pursuant to the terms of the Employment Agreement. 
 4. Executive
Representations. Executive represents and warrants that the Releasors have not filed any civil action, suit, arbitration, administrative charge, complaint, lawsuit or legal proceeding against any Company Releasee with respect to any Claims
nor has any Releasor assigned, pledged, or hypothecated, as of the Effective Date, Executive’s Claim to any person and no other person has an interest in the Claims that Executive is releasing. 

5. Acknowledgements by Executive. Executive acknowledges and agrees that Executive has read this Release in its entirety and that this Release
is a general release of all known and unknown rights and Claims, including, without limitation, of rights and Claims arising under ADEA. Executive further acknowledges and agrees that: 

(a) this Release does not release, waive or discharge any rights or claims that may arise for actions or omissions after the date of this
Release; 
 (b) Executive is entering into this Release and releasing, waiving and discharging rights or claims only in exchange for
consideration which Executive is not already entitled to receive; 
 (c) Executive has been advised, and is being advised by this Release, to
consult with an attorney before executing this Release, and Executive has consulted with counsel of Executive’s choice concerning the terms and conditions of this Release; 

(d) Executive has been advised, and is being advised by this Release, that Executive has [twenty-one
(21)][forty-five (45)]1 days within which to consider this Release, and Executive hereby acknowledges that in the event that Executive executes this Release prior to the expiration of the [twenty-one (21)][forty-five (45)]-day period, Executive waives the balance of said period and acknowledges that Executive’s waiver of such period is knowing, voluntary
and has not been induced by the Company or any Company Releasee through fraud, misrepresentation, or threat; and 
  

	1 	 Note – For enforceability of a release with respect to claims under ADEA, must give forty-five
(45) days if part of a layoff of two or more individuals or twenty-one (21) days if a single termination. 

  
 A-2 

 (e) Executive is aware that this Release shall become null and void if Executive revokes
Executive’s agreement to this Release within seven (7) days following the date of execution of this Release. Executive may revoke this Release at any time during such seven (7)-day period by
delivering (or causing to be delivered) to the Company at [], written notice of Executive’s revocation of this Release no later than 5:00 p.m. Eastern Time on the seventh (7th) full day following the date of execution of this Release (the
“Effective Date”). 
 6. Additional Agreements. Nothing in this Agreement shall prohibit Executive from filing a charge with,
providing information to or cooperating with any governmental agency and in connection therewith obtaining a reward or bounty, but Executive agrees that should any person or entity file or cause to be filed any civil action, suit, arbitration, or
other legal proceeding seeking equitable or monetary relief concerning any claim released by Executive herein, neither Executive nor any Releasor shall seek or accept any such damages or relief from or as the result of such civil action, suit,
arbitration, or other legal proceeding filed by Executive or any action or proceeding brought by another person, entity or governmental agency. In addition, nothing in this Release shall be construed to prohibit Executive from reporting or
disclosing information or reporting possible violations of federal or state law or regulations to any governmental agency or self-regulatory organization with oversight responsibility for the Company, or making other disclosures that are protected
under whistleblower or other provisions of any applicable federal or state law or regulations (it being understood that prior authorization of the Company is not required to make any such reports or disclosures, and Executive is not required to
notify the Company that Executive has made such reports or disclosures). 
 7. Non-Admission of
Liability. Executive agrees that neither this Release nor the performance by the parties hereunder constitutes an admission by any of the Releasors or Company Releasees of any violation of any federal, state or local law, regulation, common
law, breach of any contract, or any wrongdoing of any type. 
 8. Severability of Provisions. In the event that any one or more of the
provisions of this Release is held to be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions will not in any way be affected or impaired thereby. 

9. Non-Assignability. The rights and benefits available under this Release are personal to Executive and
such rights and benefits shall not be subject to assignment, alienation or transfer, except to the extent such rights and benefits are lawfully available to the estate or beneficiaries of Executive upon death. 

10. Amendment. No provision of this Release may be modified, changed, waived or discharged unless such waiver, modification, change or discharge
is agreed to in writing and signed by the Company and Executive. 

  
 A-3 

 IN WITNESS WHEREOF, the Executive has signed this Release on the date set forth
below. 
  

			
	
EXECUTIVE

 
			
		
	 By:
	 	 

 
			
	 Name:
	 	 

 
			
	 Date:
	 	 

 
			
	
	 SEATGEEK,
INC.

 
			
	 By:
	 	 

 
			
	 Name:
	 	 

 
			
	 Date:Exhibit 10.1

 

 

Execution
Version

$20,000,000

 

CARVER
BANCORP, INC.

 

Common Stock, $0.01 Par Value Per Share

Sales Agreement 

 

December 14, 2021

Piper Sandler & Co.

1251 Avenue of the Americas, 6th Floor

New York, New York 10020

Ladies and Gentlemen:

 

Carver Bancorp, Inc., a Delaware corporation
(the “Company”), the holding company for Carver Federal Savings Bank, a federally chartered savings bank (the
 “Bank”), proposes, subject to the terms and conditions stated herein, to sell from time to time through Piper
Sandler & Co., as sales agent and/or principal (the “Agent”) shares of the common stock, $.01 par value per
share (“Common Stock”), of the Company, having an aggregate gross sales price of up to $20.0 million (the
 “Shares”) on the terms set forth in this agreement (the “Agreement”).  The Company
agrees that whenever it determines to sell the Common Stock directly to the Agent, as principal or otherwise other than as set forth
in Section 2 hereof, it will enter into a separate agreement, which will include customary terms and
conditions consistent with the representations, warranties and provisions in this Agreement and which will be agreed upon by the
parties thereto (each, a “Terms Agreement”).

 

The Company has filed
with the Securities and Exchange Commission (the “Commission”) a shelf registration statement on Form S-3 (No.
333-259551), including the related prospectus, covering the registration of various securities, including the Shares, under the
Securities Act of 1933, as amended (the “1933 Act”) (the “Base Prospectus”). Such registration
statement is effective under the 1933 Act. Promptly after execution and delivery of this Agreement, the Company will prepare and
file a Prospectus Supplement (as defined below) with respect to the Shares in accordance with the provisions of Rule 430B
(“Rule 430B”) of the rules and regulations of the Commission under the 1933 Act (the “1933 Act
Regulations”) and paragraph (b) of Rule 424 (“Rule 424(b)”) of the 1933 Act Regulations. Any
information included in such Prospectus Supplement that was omitted from such registration statement at the time it became effective
but that is deemed to be part of such registration statement at the time it became effective pursuant to Rule 430B is referred to as
 “Rule 430B Information.” The shelf registration statement, at any given time, including any amendments thereto,
including post-effective amendments, the exhibits and any schedules thereto at such time, the documents incorporated by reference
therein and the documents otherwise deemed to be a part thereof or included therein by the 1933 Act, is referred to herein as the
 “Registration Statement.” The term “Effective Date” shall mean each date that the Registration
Statement and any post-effective amendment or amendments thereto became or become effective.  The term
 “Prospectus” means the prospectus supplement to the Base Prospectus that describes the Shares and the offering
thereof (the “Prospectus Supplement”) filed with the Commission pursuant to Rule 424(b) under the 1933
Act, together with the Base Prospectus, in the form used by the Agent in connection with the sale of the Shares from time to
time.  The Company will furnish to the Agent, for use by the Agent, copies of the Prospectus included as part of such
Registration Statement, as supplemented by the Prospectus Supplement, relating to the Shares.  Any registration statement filed
pursuant to Rule 462(b) of the 1933 Act Regulations is herein referred to as a
 “Rule 462(b) Registration Statement,” and after such filing the term “Registration
Statement” shall include the last filed Rule 462(b) Registration Statement.

 

    1

     

    

 

For purposes of this Agreement,
all references to the Registration Statement, the Prospectus Supplement, the Prospectus, any Issuer Free Writing Prospectus (as hereinafter
defined) or any amendment or supplement to any of the foregoing shall be deemed to include the copy, if any, filed with the Commission
pursuant to its Electronic Data Gathering, Analysis and Retrieval system (“EDGAR”).

 

As used in in this
Agreement:

 

“Applicable Time”
means, with respect to any Shares, the time of sale of such Shares pursuant to this Agreement or any relevant Terms Agreement.

 

“General Disclosure
Package” means (i) the Prospectus, (ii) the Issuer General Use Free Writing Prospectuses, if any, and (iii) any
other Issuer Free Writing Prospectus that the parties hereto shall hereafter expressly agree in writing to treat as part of the General
Disclosure Package.

 

“Issuer Free Writing
Prospectus” means any “issuer free writing prospectus,” as defined in Rule 433 of the 1933 Act Regulations
(“Rule 433”), relating to the Shares (including, without limitation, any such issuer free writing prospectus that
(i) is required to be filed with the Commission by the Company, (ii) is a “road show that is a written communication”
within the meaning of Rule 433(d)(8)(i) of the 1933 Act Regulations, whether or not required to be filed with the Commission
or (iii) is exempt from filing pursuant to Rule 433(d)(5)(i) of the 1933 Act Regulations because it contains a description
of the Shares or of the offering that does not reflect the final terms), in each case in the form filed or required to be filed with the
Commission or, if not required to be filed, in the form retained in the Company’s records pursuant to Rule 433(g) of the
1933 Act Regulations.

 

“Issuer General Use
Free Writing Prospectus” means any Issuer Free Writing Prospectus that is intended for general distribution to prospective investors.

 

“Issuer Limited-Use
Free Writing Prospectus” means any Issuer Free Writing Prospectus that is not an Issuer General Use Free Writing Prospectus.

 

All references in this Agreement
to financial statements and schedules and other information which is “contained,” “included,” “made,”
 “referred to,” or “stated” (or other references of like import) in the Registration Statement, the Prospectus
Supplement or the Prospectus shall be deemed to mean and include all such financial statements and schedules and other information which
is incorporated or deemed to be incorporated by reference in, or otherwise deemed by the 1933 Act Regulations to be a part of or included
in, the Registration Statement, the Prospectus Supplement or the Prospectus, as the case may be.

 

Section 1. Representations
and Warranties.

 

(a)               
Representations and Warranties of the Company. The Company represents and warrants
to the Agent, as of the date hereof, each Representation Date (as defined in Section 5(o) below), each Applicable
Time and each Delivery Date (as defined in Section 2(i) below), and agrees with the Agent, as follows:

 

    2

     

    

 

(i)                  Compliance
of the Registration Statement, the Prospectus and Incorporated Documents. (A)(1) At the time of filing the Registration Statement,
(2) as of the date hereof, and (3) as of each Applicable Time and Delivery Date, the Company satisfied the eligibility requirements
for the use of Form S-3 under the 1933 Act, and (B) at the date hereof, the Company was not an “ineligible
issuer” as defined in Rule 405 of the 1933 Act Regulations.  The Company has filed with the Commission the Registration
Statement on Form S-3, including a Base Prospectus for registration under the 1933 Act of the offering and sale of the Shares, and
the Company has filed with the Commission one or more amendments to such Registration Statement, each in the form previously delivered
to the Agent.  Such Registration Statement, as so amended, has been declared effective by the Commission and the Shares have been
registered under the Registration Statement in compliance with the requirements for the use of Form S-3.  The Company has not
received from the Commission any notice pursuant to Rule 401(g) of the 1933 Act Regulations objecting to the Company’s
use of Form S-3. 

 

Although the Base Prospectus
may not include all the information with respect to the Shares and the offering thereof required by the 1933 Act and the 1933 Act Regulations
to be included in the Prospectus, the Base Prospectus includes all such information required by the 1933 Act and the 1933 Act Regulations
to be included therein as of the Effective Date.  The Company has complied to the Commission’s satisfaction with all requests
of the Commission for additional or supplemental information, to the extent the Commission has requested such information in conjunction
with the filing of the Registration Statement or otherwise; and no stop order suspending the effectiveness of the Registration Statement
has been issued and no proceeding for that purpose has been initiated or, to the knowledge of the Company, threatened by the Commission. 
Promptly after the execution of this Agreement, the Company will file with the Commission pursuant to Rules 415 and 424(b)(2) or
(5) of the 1933 Act Regulations the Prospectus Supplement to the Base Prospectus included in such Registration Statement relating
to the Shares and the offering thereof, with such information as is required or permitted by the 1933 Act and as has been provided to
and approved by the Agent prior to the date hereof or, to the extent not completed at the date hereof, containing only such specific additional
information and other changes (beyond that contained in the Base Prospectus) as the Company has advised the Agent, prior to the date hereof,
will be included or made therein.  If the Company has elected to rely on Rule 462(b) of the 1933 Act Regulations and the
Rule 462(b) Registration Statement is not effective, (x) the Company will file a Rule 462(b) Registration Statement
in compliance with, and that is effective upon filing pursuant to, Rule 462(b) and (y) the Company has given irrevocable
instructions for transmission of the applicable filing fee in connection with the filing of the Rule 462(b) Registration Statement,
in compliance with Rule 111 of the 1933 Act Regulations, or the Commission has received payment of such filing fee.

 

Each of the Registration Statement
and any post-effective amendment thereto, at the time of its effectiveness and as of each deemed effective date with respect to the Agents
pursuant to Rule 430B(f)(2), complied in all material respects with the requirements of the 1933 Act and the 1933 Act Regulations. Each
of any preliminary prospectus and the Prospectus and any amendment or supplement thereto, at the time it was filed with the Commission,
complied in all material respects with the requirements of the 1933 Act and the 1933 Act Regulations and is identical to the electronically
transmitted copy thereof filed with the Commission pursuant to EDGAR, except to the extent permitted by Regulation S-T.

 

The documents incorporated
or deemed to be incorporated by reference in the Registration Statement, any preliminary prospectus and the Prospectus, when they became
effective or at the time they were or hereafter are filed with the Commission, complied and will comply in all material respects with
the requirements of the 1934 Act and the 1934 Act Regulations.

 

    3

     

    

 

(ii)                 Accurate
Disclosure. Neither the Registration Statement nor any amendment thereto, at its effective time or at any Settlement Date,
contained, contains or will contain an untrue statement of a material fact or omitted, omits or will omit to state a material fact
required to be stated therein or necessary to make the statements therein not misleading. At each Applicable Time, neither (A) the
General Disclosure Package nor (B) any individual Issuer Limited Use Free Writing Prospectus, when considered together with the
General Disclosure Package, included, includes or will include an untrue statement of a material fact or omitted, omits or will omit
to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were
made, not misleading. Neither the Prospectus nor any amendment or supplement thereto (including any prospectus wrapper), as of its
issue date, at the time of any filing with the Commission pursuant to Rule 424(b) or at any Settlement Date, included, includes or
will include an untrue statement of a material fact or omitted, omits or will omit to state a material fact necessary in order to
make the statements therein, in the light of the circumstances under which they were made, not misleading. The documents
incorporated or deemed to be incorporated by reference in the Registration Statement, the General Disclosure Package and the
Prospectus, at the time the Registration Statement became effective or when such documents incorporated by reference were or
hereafter are filed with the Commission, as the case may be, when read together with the other information in the Registration
Statement, the General Disclosure Package or the Prospectus, as the case may be, did not, do not and will not include an untrue
statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements
therein not misleading; provided, however, that the representations and warranties in this Section 1(a)(ii) shall not apply to any
statements or omissions made in reliance upon and in conformity with the Agent Information (as defined in Section 6(b) of this
Agreement.

 

(iii)                Company
Not Ineligible Issuer. . (A) At the time of filing the Registration Statement and any post-effective amendment thereto, (B)
at the earliest time thereafter that the Company or another offering participant made a bona fide offer (within the meaning of Rule 164(h)(2)
of the 1933 Act Regulations) of the Shares, (C) at the date of this Sales Agreement and any Terms Agreement and (D) at each Applicable
Time, the Company was not and is not an “ineligible issuer,” as defined in Rule 405, without taking account of any determination
by the Commission pursuant to Rule 405 that it is not necessary that the Company be considered an ineligible issuer.

 

(iii)                There
are no contracts or other documents required to be described in the Prospectus or to be filed as exhibits to the Registration Statement
which have not been described or filed as required.  The Prospectus and any amendment or supplements thereto delivered to the Agent
for use in connection with the offering of the Shares (whether to meet requests of purchasers pursuant to Rule 173 of the 1933 Act
Regulations or otherwise) was identical to the electronically transmitted copies thereof filed with the Commission pursuant to EDGAR,
except to the extent permitted by Regulation S-T under the 1933 Act.

 

(iv)                (A) at
the respective times the Registration Statement, any Rule 462(b) Registration Statement and any post-effective amendments thereto
became or becomes effective and as of the date hereof, the Registration Statement, any Rule 462(b) Registration Statement and
any amendments and supplements thereto complied and will comply in all material respects with the requirements of the 1933 Act and the
1933 Act Regulations and did not and will not contain an untrue statement of a material fact or omit to state a material fact required
to be stated therein or necessary to make the statements therein not misleading, and (B) at the time the Prospectus or any amendments
or supplements thereto were filed and at each Applicable Time and Delivery Date, neither the Prospectus nor any amendment or supplement
thereto included, includes or will include an untrue statement of a material fact or omitted, omits or will omit to state a material fact
necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided,
that the representations and warranties in clauses (A) and (B) above shall not apply to statements in or omissions from the
Registration Statement or the Prospectus made in reliance upon and in strict conformity with information furnished to the Company in writing
by the Agent expressly for use in the Registration Statement or the Prospectus, it being understood and agreed that the only such information
provided by the Agent is the Agent’s Information described in Section 8(b) hereof.  No order preventing
or suspending the use of the Prospectus or any Issuer Free Writing Prospectus has been issued by the Commission.

 

    4

     

    

 

(v)                 Issuer
Free Writing Prospectuses. Each Issuer Free Writing Prospectus, as of its issue date and at all subsequent times through the
completion of the public offer and sale of the Shares or until any earlier date that the Company notified or notifies the Agent as described
in Section 5(b), did not, does not and will not include any material information that conflicted, conflicts or
will conflict with the information contained in the Registration Statement; provided, however, that this representation and warranty shall
not apply to any statements or omissions made in reliance upon and in conformity with the Agent Information provided by the Agent expressly
for use therein.

 

(vi)               Financial
Statements; Non-GAAP Financial Measures. The consolidated financial statements of the Company, including the related schedules and
notes, filed with the Commission as a part of the Registration Statement and included in the Prospectus (the “Financial Statements”)
present fairly in all material respects the consolidated financial position of the
Company and its consolidated subsidiaries as of and at the dates indicated and the consolidated results of their operations, changes
in stockholders’ equity and cash flows of the Company and its consolidated subsidiaries for the periods specified. The Financial
Statements, unless otherwise noted therein, have been prepared in conformity with generally accepted accounting principles in effect
in the United States (“GAAP”) applied on a consistent basis throughout the periods involved,
except as may be expressly stated in the notes thereto. The selected financial data and the summary financial information included
in the Registration Statement and the Prospectus present fairly in all material respects the information therein and have been prepared
on a basis consistent with that of the audited consolidated financial statements contained in the Registration Statement, any preliminary
prospectus and the Prospectus. No other financial statements or supporting schedules are required to be included in the Registration
Statement and the Prospectus. To the extent applicable, all disclosures contained in the Prospectus regarding “non-GAAP financial
measures” as such term is defined by the rules and regulations of the Commission comply with Regulation G of the 1934 Act, the
rules and regulations of the Commission under the 1934 Act (“the “1934 Act Regulations”) and Item 10(e) of Regulation
S-K. The interactive data in eXtensible Business Reporting Language included in the Registration Statement, the General Disclosure Package
and the Prospectus presents fairly in all material respects the information included therein and has been prepared in all material respects
in accordance with the Commission’s rules and guidelines applicable thereto.

 

(vii)               Independent
Accountants. BDO USA, LLP (“BDO LLP”), the independent registered public accounting firm that audited the financial
statements of the Company and its Subsidiaries and reviewed certain unaudited financial statements of the Company and its Subsidiaries,
which in each case, are included in the Registration Statement and the Prospectus, are independent public accountants as required by the
1933 Act and the 1933 Act Regulations.

 

(viii)              Statistical
and Market-Related Data. The statistical and market-related data contained in the Registration Statement, the General Disclosure
Package and the Prospectus are based on or derived from sources which the Company believes are reliable and accurate in all material respects.

 

(ix)                Authorization
of Agreement. This Agreement has been duly authorized, executed and delivered by the Company and, when duly executed by the Agent,
will constitute the valid and binding agreement of the Company enforceable against the Company in accordance with its terms, except as
enforcement thereof may be limited by bankruptcy, insolvency, reorganization, moratorium or other similar laws relating to or affecting
creditors’ rights generally or by general equitable principles and except as any indemnification or contribution provisions thereof
may be limited under applicable securities laws, and banking laws.

 

    5

     

    

 

(x)                 No
Material Adverse Change in Business. Except as otherwise stated therein, since the respective dates as of which information is
given in the Registration Statement, the General Disclosure Package or the Prospectus, (A) the Company and its Subsidiaries,
considered as one enterprise, have not sustained any material loss or interference with its business from fire, explosion, flood or
other calamity, whether or not covered by insurance, or from any labor dispute or court or governmental action, order or decree, and
there has not been any material change in the capital stock or long-term debt of the Company and its Subsidiaries or any material
adverse change, or any development known to the Company that is reasonably expected to cause a prospective material adverse change,
in or affecting the general affairs, management, earnings, business, properties, assets, consolidated financial position,
consolidated shareholders’ equity or consolidated results of operations of the Company and its subsidiaries considered as one
enterprise, whether or not arising in the ordinary course of business (a “Material Adverse Effect, (B) there have been
no transactions entered into by the Company or any of its subsidiaries which are material with respect to the Company and its
subsidiaries considered as one enterprise, otherwise than as set forth or contemplated in the Registration Statement, the General
Disclosure Package and the Prospectus and (C) there has been no dividend or distribution of any kind declared, paid or made by the
Company on any class of its capital stock.

 

(xi)                Title
to Property. The Company and its subsidiaries have good and marketable title to all real property and good and marketable title to
all personal property owned by them, in each case free and clear of all mortgages, pledges, security interests, claims, restrictions,
liens, encumbrances and defects except such as are described generally in the Registration Statement, the General Disclosure Package and
the Prospectus or (b) do not, singly or in the aggregate, have a Material Adverse Effect; and neither the Company nor any subsidiary has
received any written or oral notice of any material claim of any sort that has been asserted by anyone adverse to the rights of the Company
or any subsidiary under any of the leases or subleases mentioned above, or affecting or questioning the rights of the Company or such
subsidiary to the continued possession of the leased or subleased premises under any such lease or sublease.

 

(xii)               Good
Standing of the Company. The Company is a savings and loan holding company under the Home Owners Loan Act of 1933, as amended,
as amended (“HOLA”), and has been duly incorporated and is validly existing as a corporation in good standing under
the laws of the State of Delaware, with the corporate power and authority to own, lease and operate its properties and to conduct its
business as described in the Registration Statement, the General Disclosure Package and the Prospectus and to enter into and perform its
obligations under this Agreement. The Company is duly qualified as a foreign corporation to transact business and is in good standing
under the laws of each other jurisdiction in which such qualification is required, whether by reason of the ownership or leasing of property
or the conduct of business, except where the failure to so qualify or to be in good standing would not reasonably be expected to result
in a Material Adverse Effect.

 

    6

     

    

 

(xiii)             Good
Standing of Subsidiaries. The Company’s only direct or indirect subsidiaries are those listed on Schedule II
of this Agreement (“Subsidiary” or “Subsidiaries”). Each of the Company’s subsidiaries,
has been duly incorporated or organized and is validly existing as a corporation or limited liability company in good standing under
the laws of the jurisdiction of its incorporation or organization, has corporate or limited liability company power and authority to
own, lease and operate its properties and to conduct its business as described in the Registration Statement, the General Disclosure
Package and the Prospectus and is duly qualified as a foreign entity to transact business and is in good standing in each
jurisdiction in which such qualification is required, whether by reason of the ownership or leasing of property or the conduct of
business, except in each case where the failure so to qualify or to be in good standing would not result in a Material Adverse
Effect. The activities of the Company’s subsidiaries are permitted of subsidiaries of a savings
and loan holding company under applicable law and the rules and regulations of the Federal Reserve Board (the
 “FRB”) set forth in Title 12 of the Code of Federal Regulations. Except as otherwise disclosed in the
Registration Statement, the General Disclosure Package and the Prospectus, all of the issued and outstanding capital stock or
membership interests of each such subsidiary has been duly authorized and validly issued, is fully paid and non-assessable (to the
extent applicable) and is owned by the Company, directly or through subsidiaries, free and clear of any security interest, mortgage,
pledge, lien, encumbrance, claim or equity. None of the outstanding shares of capital stock or membership interests of any
subsidiary was issued in violation of the preemptive or similar rights of any securityholder of such subsidiary. There are no
outstanding rights, warrants or options to acquire or instruments convertible into or exchangeable for any capital stock or equity
securities of any of the subsidiaries. Except as otherwise disclosed in the Registration Statement, the General Disclosure Package
and the Prospectus, no subsidiary of the Company is currently prohibited, directly or indirectly, from paying any dividends to the
Company, from making any other distributions on such subsidiary’s capital stock or common securities, from repaying to the
Company any loans or advances to such subsidiary from the Company or from transferring any of such subsidiary’s property or
assets to the Company or any other subsidiary of the Company.

 

(xiv)              Capitalization.
The Company has an authorized capitalization as set forth in the Registration Statement, the General Disclosure Package and the Prospectus
as of the dates referred to therein and all of the issued shares of capital stock of the Company have been duly and validly authorized
and issued, are fully paid and non-assessable. None of the outstanding shares of capital stock were issued
in violation of any preemptive rights, rights of first refusal or other similar rights to subscribe for or purchase securities of the
Company. The description of the Company’s stock option, stock bonus and other stock plans or compensation arrangements and the options
or other rights granted thereunder, incorporated by reference in the Registration Statement, the General Disclosure Package and the Prospectus,
accurately and fairly presents, in all material respects, the information required to be described therein with respect to such plans,
arrangements, options and rights. Except as described in each of the General Disclosure Package and Prospectus, there are no outstanding
rights (contractual or otherwise), warrants or options to acquire, or instruments convertible into or exchangeable for, or agreements
or understandings with respect to the sale or issuance of, any shares of capital stock of or other equity interest in the Company, other
than in the ordinary course of business, consistent with past practice, under the Company’s equity compensation programs.

 

(xv)              Authorization
and Description of Securities. The Shares have been duly and validly authorized and, when issued, delivered to and paid for by the
Agent pursuant to this Agreement, will be validly issued, fully paid and nonassessable,
and will conform to the description of the capital stock contained in each of the Registration Statement, the General Disclosure Package
and the Prospectus. Except as disclosed in the Registration Statement, the General Disclosure Package and the Prospectus, the issuance
of the Shares is not subject to the preemptive or other similar rights of any securityholder of the Company.

 

(xvi)              Absence
of Violations, Defaults and Conflicts. Neither the Company nor any of its Subsidiaries is (A) in violation of its certificate
of incorporation, charter, by-laws or similar organizational document, (B) in default in the performance or observance
of any obligation, agreement, covenant or condition contained in any contract, indenture, mortgage, deed of trust, loan or credit agreement,
note, lease or other agreement or instrument to which the Company or any of its Subsidiaries is a party or by which it or any of them
may be bound or to which any of the properties or assets of the Company or any Subsidiary is subject (collectively, “Agreements
and Instruments”), except for such defaults that would not reasonably be expected to, singly or in the aggregate, result in
a Material Adverse Effect, or (C) in violation of any law, statute, rule, regulation, judgment, order, writ or decree of any arbitrator,
court, governmental body, regulatory body, administrative agency or other authority, body or agency having jurisdiction over the Company
or any of its Subsidiaries or any of their respective properties, assets or operations (each, a “Governmental Entity”),
except for such violations that would not reasonably be expected to, singly or in the aggregate, result in a Material Adverse Effect.

 

    7

     

    

 

The execution, delivery and
performance of this Agreement and the consummation of the transactions contemplated herein and in the Registration Statement, the General
Disclosure Package and the Prospectus (including the issuance and sale of the Shares and the use of the proceeds from the sale of the
Shares as described therein under the caption “Use of Proceeds”) and compliance by the Company with its obligations hereunder
have been duly authorized by all necessary corporate action and do not and will not, whether with or without the giving of notice or passage
of time or both, conflict with or constitute a breach of, or default or Repayment Event (as defined below) under, or result in the creation
or imposition of any lien, charge or encumbrance upon any properties or assets of the Company or any Subsidiary pursuant to, the Agreements
and Instruments (except for such conflicts, breaches, defaults or Repayment Events or liens, charges or encumbrances that would not reasonably
be expected to, singly or in the aggregate, result in a Material Adverse Effect), nor will such action result in any violation of (x) the
provisions of the charter, bylaws or similar organizational document of the Company or any of its Subsidiaries or (y) subject
to compliance by all necessary persons with the applicable provisions of the Change in Bank Control Act of 1978 and Regulation Y promulgated
in part thereunder, any law, statute, rule, regulation, judgment, order, writ or decree of any Governmental Entity, except, with respect
to clause (y), such violations as would not reasonably be expected to, singly or in the aggregate, result in a Material Adverse Effect.

 

As used herein, a “Repayment
Event” means any event or condition which gives the holder of any note, debenture or other evidence of indebtedness (or any
person acting on such holder’s behalf) the right to require the repurchase, redemption or repayment of all or a portion of such
indebtedness by the Company or any of its Subsidiaries.

 

(xvii)             Consents
and Approvals. No consent, approval, authorization, order, registration or qualification of or with any such court or governmental
agency or body is required for the issue and sale of the Shares, the performance by the Company of its obligations hereunder or the consummation
by the Company of the transactions contemplated by this Agreement, except the registration under the 1933 Act of the Shares and except
as may be required under the rules and regulations of the Nasdaq Capital Market (“NASDAQ”) or the Financial Industry
Regulatory Authority (“FINRA”) and such consents, approvals, authorizations, registrations or qualifications as may
be required under state securities or Blue Sky laws in connection with the purchase and distribution of the Shares by the Agent.

 

(xviii)            Conduct
of Business. Except as disclosed in the Registration Statement, the General Disclosure Package and the Prospectus, the Company and
its subsidiaries have conducted and are conducting their respective businesses in compliance in all material respects with all federal,
state, local and foreign statutes, laws, rules, regulations, decisions, directives and orders and administrative and court decrees applicable
to them (including, without limitation, all regulations and orders of, or agreements with, the FRB, the Office of the Comptroller of the
Currency (“OCC”), the Federal Deposit Insurance Corporation (the “FDIC”), and the Commission, the
Equal Credit Opportunity Act, the Fair Housing Act, the Community Reinvestment Act, the Home Mortgage Disclosure Act, all other applicable
fair lending laws or other laws relating to discrimination and the Bank Secrecy Act and Title III of the USA Patriot Act), and neither
the Company nor any of its subsidiaries has received any written or oral communication from any Governmental Entity asserting that the
Company or any of its subsidiaries is not in compliance with any statute, law, rule, regulation, decision, directive or order that would
reasonably be expected to result in a Material Adverse Effect.

 

    8

     

    

 

(xix)              Absence
of Proceedings. There are no legal or governmental actions or suits, investigations, inquiries or proceedings before or by any court
or Government Entity, now pending or, to the knowledge of the Company, threatened or contemplated, to which the Company or any of its
subsidiaries is a party or of which any property of the Company or any of its subsidiaries is the subject (A) that is required to be
disclosed in the Registration Statement by the 1933 Act or the 1933 Act Regulations and is not disclosed therein or (B) which, if not
disclosed in the Registration Statement, if determined adversely to the Company or any of its subsidiaries, would be reasonably expected
to result, individually or in the aggregate, in a Material Adverse Effect; all pending legal or governmental proceedings to which the
Company or any of its subsidiaries is a party or of which any of their property is the subject which are not described in the Registration
Statement, including ordinary routine litigation incidental to their respective businesses, are not reasonably expected to result, individually
or in the aggregate, in a Material Adverse Effect, and there are no contracts or documents of the Company or any of its subsidiaries
which would be required by the 1933 Act or the 1933 Act Regulations to be described in the Registration Statement or to be filed as exhibits
thereto which have not been so described or filed.

 

(xx)               Possession
of Licenses and Permits. Each of the Company and its subsidiaries (A) possesses all permits, licenses, approvals, consents and other
authorizations (collectively, “Governmental Licenses”) of any Governmental Entity, (B) has made all filings, applications
and registrations with, any Governmental Entity necessary to permit the Company or such subsidiary to conduct the business now operated
by the Company or such subsidiary, and (C) is in compliance with the terms and conditions of all such Governmental Licenses, except where
the failure to so possess, file, apply, register or comply would not, individually or in the aggregate, have a Material Adverse Effect.
All of the Governmental Licenses currently held by the Company or any of its subsidiaries are valid and in full force and effect, except
where the invalidity of such Governmental Licenses or the failure of such Governmental Licenses to be in full force and effect would not,
individually or in the aggregate, have a Material Adverse Effect, and neither the Company nor any of its subsidiaries has received any
notice of proceedings relating to the revocation or modification of any such material Governmental Licenses. Neither the Company nor any
its subsidiaries have failed to file with applicable regulatory authorities any statement, report, information or form required by any
applicable law, regulation or order, except where the failure to so file in compliance would not, individually or in the aggregate, have
a Material Adverse Effect; all such filings were in compliance in all material respects with applicable laws when filed and no material
deficiencies have been asserted in writing by any regulatory commission, agency or authority with respect to any such filings or submissions.

 

(xxi)              Environmental
Laws. Except as disclosed in the Registration Statement, the General Disclosure Package and the Prospectus and except as would not,
individually or in the aggregate, result in a Material Adverse Effect, (A) neither the Company nor any of its subsidiaries is in violation
of any federal, state or local statute, law, rule, regulation, ordinance, or code or any applicable judicial or administrative interpretation
thereof, including any judicial or administrative order, consent, decree or judgment, relating to pollution or protection of human health,
the environment (including, without limitation, ambient air, surface water, groundwater, land surface or subsurface strata) or wildlife,
including, without limitation, laws and regulations relating to the release or threatened release of chemicals, pollutants, contaminants,
wastes, toxic substances, hazardous substances, petroleum or petroleum products, asbestos-containing materials or mold (collectively,
 “Hazardous Materials”) or to the manufacture, processing, distribution, use, treatment, storage, disposal, transport
or handling of Hazardous Materials (collectively, “Environmental Laws”), (B) each of the Company and its subsidiaries
has all permits, authorizations and approvals required to be held by it under any applicable Environmental Laws and are in compliance
with the requirements of each such permit, authorization and approval held by it, (C) there are no pending or, to the knowledge of the
Company, threatened administrative, regulatory or judicial actions, suits, demands, demand letters, claims, liens, notices of noncompliance
or violation, investigation or proceedings relating to any Environmental Law against the Company or any of its subsidiaries, and (D) there
are no events or circumstances that would reasonably be expected to form the basis of an order for clean-up or remediation, or an action,
suit or proceeding by any private party or Governmental Entity, against or affecting the Company or any of its subsidiaries relating to
Hazardous Materials or any Environmental Laws.

 

    9

     

    

 

(xxii)             Possession
of Intellectual Property. The Company and each of its subsidiaries own or possess adequate rights to use or can acquire on
reasonable terms ownership or rights to use all patents, patent applications, patent rights, licenses, trademarks, service marks,
trade names, trademark registrations, service mark registrations, copyrights and know-how (including trade secrets and other
unpatented and/or unpatentable proprietary or confidential information, systems or procedures and excluding generally commercially
available “off the shelf” software programs licensed pursuant to shrink wrap or “click and accept” licenses)
and licenses (collectively, “Intellectual Property”) necessary for the conduct of their respective businesses,
except in each case where the failure to own or possess such rights would not, individually or in the aggregate, result in a
Material Adverse Effect, and have not received any notice of any claim of infringement or conflict with, any such rights of others
or any facts or circumstances that would render any Intellectual Property invalid or inadequate to protect the interest of the
Company or any of its subsidiaries therein, except in each case where such infringement or conflict (if the subject of any
unfavorable decision, ruling or finding) or invalidity or inadequacy, individually or in the aggregate, would not result in a
Material Adverse Effect.

 

(xxiii)            Transactions
with Related Parties. No relationship, direct or indirect, exists between or among the Company or any of its subsidiaries on the one
hand, and the directors, officers, shareholders, customers or suppliers of the Company or any of its subsidiaries on the other hand, which
is required to be disclosed in the Registration Statement and the Prospectus by the 1933 Act or the 1933 Act Regulations which has not
been so disclosed.

 

(xxiv)            Investment
Company Act. Neither the Company nor any of its subsidiaries is, or after giving effect to the offering and sale of the Shares, and
after receipt of payment for the Shares and the application of the net proceeds as described in each of the Registration Statement, the
General Disclosure Package and the Prospectus, will be an “investment company,” as such term is defined in the Investment
Company Act of 1940, as amended (the “Investment Company Act”).

 

(xxv)            
Compliance with the Sarbanes-Oxley Act. The Company is in compliance in all material respects with the provisions of the Sarbanes-Oxley
Act and the rules and regulations of the Commission thereunder applicable to the Company and the Company is in compliance in all material
respects with the applicable rules and regulations of NASDAQ. The Company has taken no action designed to, or likely to have the effect
of, terminating the listing of the Company’s common stock on the Nasdaq Capital Market , nor has the Company received notification
that NASDAQ is contemplating terminating such listing. There is no requirement to receive the approval of the NASDAQ for the Shares to
be listed on the Nasdaq Capital Market.

 

(xxvi)           
Absence of Manipulation. Neither the Company nor any of its Subsidiaries, nor any affiliates of the Company or its Subsidiaries,
has taken or will take, directly or indirectly, any action designed to or that would be reasonably expected to cause or result in stabilization
or manipulation of the price of any securities of the Company to facilitate the sale or resale of the Shares or to result in a violation
of Regulation M under the 1934 Act.

 

(xxvii)           Foreign
Corrupt Practices Act. Neither the Company nor any of its Subsidiaries, nor, to the knowledge of the Company, any director,
officer, employee or agent or other person acting on behalf of the Company or any of its Subsidiaries has (A) used any corporate
funds of the Company or any of its Subsidiaries for any unlawful contribution, gift, entertainment or other unlawful expense relating
to political activity, (B) made any direct or indirect unlawful payment to any foreign or domestic government official or employee
from corporate funds of the Company or any of its Subsidiaries, (C) violated or is in violation of any provision of the Foreign Corrupt
Practices Act of 1977, and the Company has instituted and maintains policies and procedures designed to ensure compliance therewith, (D) made
any bribe, illegal rebate, payoff, influence payment, kickback or other unlawful payment, (E) materially violated applicable privacy of
customer information requirements contained in any federal or state privacy act laws and regulations; or (F) made any payment of funds
to the Company or any of its Subsidiaries or received or retained funds in violation of any law, rule or regulation.

 

    10

     

    

 

(xviii)           Accounting
and Disclosure Controls. The Company and its Subsidiaries, on a consolidated basis, maintain a system of effective internal control
over financial reporting (as defined under Rule 13-a15 and 15d-15 under the 1934 Act Regulations) and a system of internal accounting
controls sufficient to provide reasonable assurances that (A) transactions are executed in accordance with management’s general
or specific authorization; (B) transactions are recorded as necessary to permit preparation of financial statements in conformity
with GAAP and to maintain accountability for assets; (C) access to assets is permitted only in accordance with management’s
general or specific authorization; and (D) the recorded accountability for assets is compared with the existing assets at reasonable
intervals and appropriate action is taken with respect to any differences.

 

Except as described in the
Registration Statement, the General Disclosure Package and the Prospectus, since the end of the Company’s most recent audited fiscal
year, there has been (1) no material weakness in the Company’s internal control over financial reporting (whether or not remediated)
and (2) no change in the Company’s internal control over financial reporting that has materially and adversely affected, or
is reasonably likely to materially and adversely affect, the Company’s internal control over financial reporting.

 

(xvix)            Regulatory
Matters. Neither the Company nor the Bank is in violation of any order or directive from the FRB, the OCC, the FDIC, the Commission
or any regulatory authority to make any material change in the method of conducting its respective businesses; the Company and the Bank
have conducted and are conducting their business so as to comply in all material respects with all applicable statutes, regulations and
administrative and court decrees (including, without limitation, all regulations, decisions, directives and orders of the FRB, the OCC,
the FDIC and the Commission). Except as required to be disclosed in the Registration Statement, the General Disclosure Package and the
Prospectus, neither the Company nor any of its Subsidiaries is subject or is party to, or has received any notice or advice that any
of them may become subject or party to, any investigation with respect to, any corrective, suspension or cease-and-desist order, agreement,
consent agreement, memorandum of understanding or other regulatory enforcement action, proceeding or order with or by, or is a party
to any commitment letter, or is subject to any directive by, or has been a recipient of any supervisory letter from any Regulatory Agency
(as defined below) that, in each case, currently relates to or restricts in any respect the conduct of their business or that in any
manner relates to capital adequacy, credit policies or management, nor at the request or direction of any Regulatory Agency has the Company
or any of its Subsidiaries adopted any board resolution that is reasonably likely to have a Material Adverse Effect (each, a “Regulatory
Agreement”), nor has the Company or any of its Subsidiaries been advised by any Regulatory Agency that it is considering issuing
or requesting any such Regulatory Agreement or any such Regulatory Agreement is pending or, to the knowledge of the Company, threatened.
Except as required to be disclosed in the Registration Statement, the General Disclosure Package and the Prospectus, the Company and
its Subsidiaries are each in substantial compliance with any Regulatory Agreements, and there is no unresolved violation, criticism or
exception by any Regulatory Agency with respect to any report or statement relating to any examinations of the Company or any of its
Subsidiaries which, in the reasonable judgment of the Company, currently results in or would reasonably be expected to result in a Material
Adverse Effect. As used herein, the term “Regulatory Agency” means any Governmental Entity having supervisory or regulatory
authority with respect to the Company or any of its Subsidiaries, including, but not limited to, any federal or state agency charged
with the supervision or regulation of depositary institutions or holding companies of depositary institutions, or engaged in the insurance
of depositary institution deposits.

 

    11

     

    

 

(xxx)             Employee
Benefit Plans. Each “employee benefit plan” (as defined under the Employee Retirement Income Security Act of 1974,
as amended, and the regulations and published interpretations thereunder (collectively, “ERISA”)) established or
maintained by the Company, its subsidiaries or their “ERISA Affiliates” (as defined below) is in compliance with ERISA,
except where the failure to be in compliance with ERISA would not result in a Material Adverse Effect. “ERISA
Affiliate” means, with respect to the Company or a subsidiary, any member of any group of organizations described in
Section 414(b), (c), (m) or (o) of the Internal Revenue Code of 1986, as amended, and the regulations and published interpretations
thereunder (the “Code”) of which the Company or such subsidiary is a member. No “reportable event” (as
defined under ERISA) has occurred or is reasonably expected to occur with respect to any “employee benefit plan”
established or maintained by the Company, its subsidiaries or any of their ERISA Affiliates. The fair market value of the assets of
each ERISA Affiliate defined benefit pension plan exceeds the present value of such plan’s “benefit liabilities”
(as defined in Section 4001(a)(16) of ERISA), and no ERISA Affiliate defined benefit pension plan has an “accumulated funding
deficiency” (as defined in Section 302 of ERISA). None of the Company, its subsidiaries nor any of their ERISA Affiliates has
incurred or reasonably expects to incur any liability under (A) Title IV of ERISA with respect to termination of, or withdrawal
from, any “employee benefit plan” or (B) Sections 412, 4971 or 4975 of the Code. Each “employee benefit
plan” established or maintained by the Company, its subsidiaries or any of their ERISA Affiliates that is intended to be
qualified under Section 401(a) of the Code has received a favorable determination or opinion letter from the Internal Revenue
Service regarding its qualification under such section and, to the knowledge of the Company, its subsidiaries and its ERISA
affiliates, nothing has occurred whether by action or failure to act, which would cause the loss of such qualification.

 

(xxxi)            
Insurance. The Company and its subsidiaries, taken as a whole, are insured by insurers of recognized financial responsibility against
such losses and risks and in such amounts as the Company reasonably believes are prudent and customary in the business in which the Company
and its subsidiaries are engaged. Neither the Company nor any of its subsidiaries has any reason to believe that it will not be able to
obtain insurance coverage from insurers similar to their current insurers as may be necessary to continue its business at a cost that
would not have a Material Adverse Effect. To the knowledge of the Company, neither the Company nor any subsidiary has been denied any
insurance coverage which it has sought or for which it has applied in any instance in which such insurance coverage was offered by the
carrier from which the Company or such subsidiary sought such coverage or to which it applied for such coverage.

 

(xxxii)          
Payment of Taxes. The Company and its subsidiaries have (i) filed all necessary federal, state and foreign income and franchise
tax returns that they are required to have filed or have properly requested extensions of the deadline for the filing therefor and all
such tax returns as filed are true, complete and correct in all material respects and (ii) have paid all taxes required to be paid by
any of them, other than such taxes as may be paid at a later date without any penalty or fine and except for any such tax, assessment,
fine or penalty that is currently being contested in good faith by appropriate actions and except for such taxes, assessments, fines or
penalties, the nonpayment or late payment of which would not, individually or in the aggregate, be reasonably expected to have a Material
Adverse Effect.

 

(xxxiv)         Absence of Labor
Dispute. No labor dispute with the employees of the Company or any subsidiary exists or, to the knowledge of the Company, is imminent,
which, in any case, would reasonably be expected to result in a Material Adverse Effect.

 

(xxxv)          Money Laundering
Laws. Except as disclosed in the Registration Statement, the General Disclosure Package and the Prospectus, the operations of the
Company and its subsidiaries are and have been conducted at all times in compliance in all material respects with applicable financial
recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, money laundering
statutes applicable to the Company and its subsidiaries, the rules and regulations thereunder and any related or similar rules, regulations
or guidelines, issued, administered or enforced by any governmental agency (collectively, the “Money Laundering Laws”),
and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company
or any of its subsidiaries with respect to the Money Laundering Laws is pending or, to the knowledge of the Company, threatened.

 

    12

     

    

 

(xxxvi)         
Cybersecurity. (A) To the Company’s knowledge, there has been no security breach or incident, attack, or other compromise
of or relating to any of the Company or its Subsidiaries information technology and computer systems, networks, hardware, software, data
and databases (including the data of their respective customers, employees, suppliers, vendors and any third party data maintained, processed
or stored by the Company and its Subsidiaries, and any such data processed or stored by third parties on behalf of the Company and its
Subsidiaries), equipment or technology (collectively, “IT Systems and Data”): (B) neither the Company nor its Subsidiaries
have been notified of, and each of them have no knowledge of any event or condition that could result in, any security breach or incident,
attack or other compromise to their IT Systems and Data and (C) the Company and its Subsidiaries have implemented appropriate controls,
policies, procedures, and technological safeguards reasonably likely to maintain and protect the integrity, continuous operation, redundancy
and security of their IT Systems and Data reasonably consistent with industry standards and practices, or as required by applicable regulatory
standards, except in the case of (A), (B) or (C) where the breach, incident attack or other compromise, event or condition or failure
to implement appropriate controls, policies, procedures and technological safeguards would not, individually or in the aggregate, have
a Material Adverse Effect. The Company and its Subsidiaries are presently in material compliance with all applicable laws or statutes
and all judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies
and contractual obligations relating to the privacy and security of IT Systems and Data and to the protection of such IT Systems and Data
from unauthorized use, access, misappropriation or modification, except as would not be reasonably expected to result in a Material Adverse
Effect.

 

(xvii)            No Distribution.
The Company has not distributed and, prior to the later to occur of (i) the Delivery Date and (ii) completion of the distribution of the
Shares, will not distribute any offering materials in connection with the offering and sale of the Shares other than the Prospectus and,
subject to compliance with the terms and conditions herein, any Issuer Free Writing Prospectus.

 

(xviii)          
Swaps; Futures; Etc. Any and all material swaps, caps, floors, futures, forward contracts, option agreements (other than employee
stock option and restricted stock shares) and other derivative financial instruments, contracts or arrangements, whether entered into
for the account of the Company or one of its subsidiaries or for the account of a customer of the Company or one of its subsidiaries,
were entered into in the ordinary course of business and in accordance with prudent business practice and applicable laws, rules, regulations
and policies of all applicable regulatory agencies and with counterparties believed to be financially responsible at the time of execution
of such instruments, contracts or arrangements. The Company and each of its subsidiaries have duly performed all of their respective
obligations thereunder to the extent that such obligations to perform have accrued, and there are no breaches, violations or defaults
or allegations or assertions of such by any party thereunder, except for such breaches, violations, defaults, allegations or assertions
that, individually or in the aggregate, would not reasonably be expected to result
in a Material Adverse Effect.

 

(xix)              OFAC.
Neither the Company nor, to the knowledge of the Company, any director, officer, agent, employee or affiliate of the Company is (a) currently
subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”);
or (b) located, organized or resident in a country or territory that is the subject of such sanctions (including, without limitation,
Burma/Myanmar, Cuba, Iran, North Korea, Sudan and Syria). The Company will not, directly
or indirectly, use the proceeds of the offering contemplated hereby, or lend, contribute or otherwise make available such proceeds to
any of its subsidiaries, any joint venture partner of the Company or any of its subsidiaries or any other person or entity, for the purpose
of financing the activities of any person, or engage in dealings or transactions with any person, or in any country, or territory, subject
to any U.S. sanctions administered by OFAC.

 

    13

     

    

 

(xl)               Off-Balance
Sheet Transactions. Except as described in the Registration Statement, General Disclosure Package or the Prospectus, there are no
material off-balance sheet transactions, arrangements, obligations (including contingent obligations), or any other relationships with
unconsolidated entities or other persons to which the Company or any of its subsidiaries is a party, that would reasonably be expected
to have, individually or in the aggregate, a Material Adverse Effect.

 

(xli)             
No FINRA Affiliations. To the knowledge of the Company, after due inquiry of its officers and directors, there are no affiliations
with any FINRA member firm among the Company’s officers or directors, or principal shareholders, except as set forth in the Registration
Statement, the General Disclosure Package and the Prospectus, or as otherwise disclosed in writing to the Agent.

 

(xliii)             Accuracy of FINRA
Information. All of the information, as may have been updated or amended, provided to the Agent or to counsel for the Agent by the
Company, its officers and directors and, to the Company’s knowledge, the holders of any securities (debt or equity) or options to
acquire any securities of the Company in connection with letters, filings or other supplemental information provided to FINRA pursuant
to FINRA Rule 5110 and FINRA Rule 5121 is true, complete and correct

 

(b)                Representations
and Warranties of Bank. The Bank represents and warrants to the Agent, as of the date hereof, each Representation Date (as
defined in Section 5(o) below), each Applicable Time (as defined herein) and each Delivery Date (as defined in Section 2(i)
hereof), and agrees with the Agent, as follows:

(i)                 Good
Standing of Bank. The Bank is the only depository institution subsidiary of the Company and the Bank is a member in good standing
of the Federal Home Loan Bank System. The activities of the Bank are permitted under the laws and regulations of the OCC and the FRB and
the deposit accounts in the Bank are insured up to the applicable limits by the FDIC and no proceeding for the termination or revocation
of such insurance is pending or, to the knowledge of the Bank, threatened against the Bank.

 

(ii)                
Absence of Violations by Bank. The Bank is not in violation of its charter or bylaws or in default in the performance or observance
of any obligation, agreement, covenant or condition contained in any indenture, mortgage, deed of trust, loan agreement, note, lease or
other agreement or instrument to which it is a party or by which it or any of its properties may be bound or to which any of the property
or assets of the Bank is subject except for such defaults that would not result in a Material Adverse Effect.

 

(iii)               Authorization of
Agreement by Bank. This Agreement has been duly authorized, executed and delivered by the Bank and, when duly executed by the Agent,
will constitute the valid and binding agreement of the Bank, enforceable against the Bank in accordance with its terms, except as enforcement
thereof may be limited by bankruptcy, insolvency, reorganization, moratorium or other similar laws relating to or affecting creditors’
rights generally or by general equitable principles and except as any indemnification or contribution provisions thereof may be limited
under applicable securities laws and banking laws. The Bank has the full power and authority to enter into this Agreement.

 

(iv)
              Defaults and Conflicts. The execution, delivery
and performance of this Agreement by the Bank and the compliance and performance by the Bank with all of the provisions of this
Agreement and the consummation of the transactions herein contemplated have been duly authorized by all necessary corporate action
on the part of the Bank and do not and will not, whether with or without the giving of notice or passage or time or both, conflict
with or result in a breach or violation of any of the terms or provisions of, or constitute a default or result in a Repayment Event
under, any indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which the Bank is a party or by
which the Bank is bound or to which any of the property or assets of the Bank is subject, nor will such action result in any
violation of the provisions of the articles of incorporation or bylaws of the Bank or any statute or any order, rule or regulation
of any Governmental Entity having jurisdiction over the Bank or any of its properties, except for those conflicts, breaches,
violations, defaults or Repayment Events that would not result in a Material Adverse Effect.

 

    14

     

    

 

(c)                Officer’s
Certificates. Any certificate signed by an officer of the Company or the Bank and delivered to the Agent or to counsel for the Agent
in connection with the offering of Shares shall be deemed to be a representation and warranty by the Company or the Bank, as applicable,
to each Agent as to the matters set forth therein as of the date of such certificate.

 

SECTION 2. SALE AND DELIVERY
OF SHARES.

 

(a)                 On
the basis of the representations, warranties and agreements herein contained and subject to the terms and conditions set forth herein,
upon the Agent’s acceptance of the terms of a Placement Notice (as defined in Section (b) ) or such other
instructions provided by the Company to the Agent pursuant to Section 2(b) or upon receipt by the Agent of an Acceptance
(as defined in Section 2(c) ), as the case may be, and unless the sale of the Placement Shares (as defined in Section 2(b))
described therein has been declined, suspended or otherwise terminated in accordance with the terms of this Agreement, the Company agrees
to issue and sell through the Agent, as sales agent, and the Agent agrees, subject to the limitations and provisions in this Section 2 or as
may otherwise be agreed to between the parties from time to time, to use its commercially reasonable efforts consistent with its normal
trading and sales practices to sell as sales agent for the Company, the Shares.  Sales of the Shares, if any, through the Agent acting
as sales agent will be made by means of ordinary brokers’ transactions or otherwise at market prices prevailing at the time of sale,
at prices related to prevailing market prices or at negotiated prices.

 

(b)                 The
Shares are to be sold on a daily basis or otherwise as shall be agreed to by the Company and the Agent on any day that is a trading day
for the Nasdaq Capital Market (other than a day on which the NASDAQ Stock Market is scheduled to close prior to its regular weekday closing
time) (each, a “Trading Day”), and the Company has instructed the Agent to make such sales.  Prior to the commencement
of the offering, when the Company wishes to issue and sell the Shares hereunder, it will notify the Agent at least one “business
day,” as defined in Rule 100 of Regulation M of the 1933 Act Regulations (a “Regulation M Business Day”),
to the extent Regulation M is applicable to the Company, prior to the Trading Day on which sales are desired to commence by e-mail notice
(or other method mutually agreed to in writing by the parties) containing the parameters in accordance with which it desires the Shares
to be sold, which shall at a minimum include the number of Shares desired to be issued (the “Placement Shares”), a
form of which is attached hereto as Annex I (a “Placement Notice”).  The Placement Notice
shall originate from any of the individuals from the Company set forth on Schedule I  (with a copy to each of
the other individuals from the Company listed on such schedule), and shall be addressed to each of the individuals from the Agent set
forth on Schedule I, as such Schedule I may be amended from time to time.  On any Trading
Day that the Company wishes to issue and sell the Shares hereunder (each, a “Placement”), the Company may instruct
the Agent by telephone (confirmed promptly by telecopy or email, which confirmation will be promptly acknowledged by the Agent), or such
other method mutually agreed to in writing by the parties, as to the maximum number of Shares to be sold by the Agent on such day (in
any event not in excess of the number available for sale under the Prospectus and the currently effective Registration Statement) and
the minimum price per Share at which such Shares may be sold.

 

    15

     

    

 

(c)                 If
the Agent wishes to accept such proposed terms included in the Placement Notice (which it may decline to do for any reason in its
sole discretion) or, following discussion with the Company, wishes to accept amended terms, the Agent will, prior to
4:30 p.m. (New York City Time) on the business day following the business day on which such Placement Notice is delivered
to the Agent, issue to the Company a notice by e-mail (or other method mutually agreed to in writing by the parties) addressed to
all of the individuals from the Company and Agent set forth on Schedule I) setting forth the terms that the Agent is
willing to accept.  Where the terms provided in the Placement Notice are amended as provided for in the immediately preceding
sentence, such terms will not be binding on the Company or the Agent until the Company delivers to the Agent an acceptance by e-mail
(or other method mutually agreed to in writing by the parties) of all of the terms of such Placement Notice, as amended (the
 “Acceptance”), which e-mail shall be addressed to all of the individuals from the Company and the Agent set forth
on Schedule I.  The Placement Notice (as amended by the corresponding Acceptance, if applicable) shall be
effective upon receipt by the Company of the Agent’s acceptance of the terms of the Placement Notice or upon receipt by the
Agent of the Company’s Acceptance, as the case may be, unless and until (i) the entire amount of the Placement Shares has
been sold, (ii) in accordance with the notice requirements set forth in the second sentence
of Section 2(d) below, the Company terminates the Placement Notice, (iii) the Company issues
a subsequent Placement Notice with parameters superseding those on the earlier dated Placement Notice, (iv) this Agreement
has been terminated under the provisions of Section 9 or (v) either party shall have suspended the sale
of the Placement Shares in accordance with the terms of this Agreement. It is expressly acknowledged and agreed that neither the
Company nor the Agent will have any obligation whatsoever with respect to a Placement or any Placement Shares unless and until the
Company delivers a Placement Notice to the Agent and either (i) the Agent accepts the terms of such Placement Notice or
(ii) where the terms of such Placement Notice are amended, the Company accepts such amended terms by means of an Acceptance
pursuant to the terms set forth above, and then only upon the terms specified in the Placement Notice (as amended by the
corresponding Acceptance, if applicable) and herein.  In the event of a conflict between the terms of this Agreement and the
terms of a Placement Notice (as amended by the corresponding Acceptance, if applicable), the terms of the Placement Notice (as
amended by the corresponding Acceptance, if applicable) will control.

 

(d)                Notwithstanding
the foregoing, the Company shall not authorize the issuance and sale of, and the Agent shall not be obligated to use its commercially
reasonable efforts to sell, any Shares (i) at a price lower than the minimum price therefor authorized from time to time, or (ii) in
a number in excess of the aggregate number of shares or gross sale price of Shares authorized from time to time to be issued and sold
under this Agreement, in each case, by the Company’s board of directors (the “Board”) or a duly authorized committee
or subcommittee thereof (the “Designated Subcommittee”), and notified to the Agent in writing.  In addition, the
Company or the Agent may, upon notice to the other party hereto by telephone (confirmed promptly by e-mail to those individuals specified
on Schedule I), suspend or terminate the offering of the Shares for any reason and at any time; provided, however,
that such suspension or termination shall not affect or impair the parties’ respective obligations with respect to the Shares sold
hereunder or which an investor has agreed to purchase but which have not been delivered by the Company and paid for by such investor as
contemplated hereby, prior to the giving of such notice.

 

(e)                Under
no circumstances shall the aggregate gross sale price or number of Shares sold pursuant to this Agreement exceed the aggregate gross sale
price or number of shares, as the case may be, of Common Stock (i) set forth in the preamble paragraph of this Agreement, (ii) available
for issuance under the Prospectus and the then currently effective Registration Statement or (iii) authorized from time to time to
be issued and sold under this Agreement by the Board or the Designated Subcommittee and notified to the Agent in writing.  In addition,
under no circumstances shall any Shares be sold at a price lower than the minimum price therefor authorized from time to time by the Board
or the Designated Subcommittee and notified to the Agent in writing.  The Agent covenants and agrees not to make any sales of the
Shares on behalf of the Company other than as permitted by the terms of this Agreement.

 

    16

     

    

 

(f)                 Subject
to the terms of the Placement Notice (as amended by the corresponding Acceptance, if applicable) or such other instructions provided
by the Company to the Agent pursuant to Section 2(b), the Agent may sell Placement Shares by any method permitted
by law deemed to be an “at the market” offering as defined in Rule 415 of the Act, including without limitation
sales made directly on the Nasdaq Capital Market, on any other existing trading market for the Common Stock or to or through a
market maker.  Subject to the terms of the Placement Notice (as amended by the corresponding Acceptance, if applicable) or such
other instruction provided by the Company to the Agent pursuant to Section 2(b), the Agent may also sell Placement
Shares by any other method permitted by law, including but not limited to privately negotiated transactions subject to the approval
of the Company.  Notwithstanding anything to the contrary herein and for a period of time beginning one Regulation M Business
Day prior to the time when the first sale pursuant to a Placement Notice occurs, to the extent Regulation M is applicable, and
continuing through the time such Placement Notice is in effect, (i) the Agent agrees that in no event will it or any of its
affiliates engage in any market making, stabilization or other market or trading activity with regard to the Shares if such activity
would be prohibited under Regulation M or other anti-manipulation rules under the 1933 Act or the 1934 Act; and (ii) the
Company agree agrees that in no event will it or any of its affiliates engage in any trading activity with respect to the Shares or
attempt to induce any other person to bid for or purchase the Shares if such activity would be prohibited under Regulation M.

 

(g)                The
compensation payable to the Agent for sales of Shares shall be equal to 3.0% of the aggregate purchase price of the Shares sold in
the offering. The remaining proceeds, after further deduction for any transaction fees, transfer taxes or other similar fees, taxes or
charges imposed by any federal, state, local or other governmental, regulatory or self-regulatory organization in respect of such sales,
shall constitute the net proceeds to the Company for such Shares (the “Net Proceeds”).  The Agent shall notify
the Company as promptly as practicable if any deduction described in the preceding sentence will be required.

 

(h)                The
Agent shall provide written confirmation (which may be by e-mail) to the Company following the close of trading on the Nasdaq Capital
Market each day on which Shares are sold under this Agreement setting forth the number of Shares sold on such day, the gross sales prices
of the Shares, the volume weighted average price for all sales of the Company’s common stock (including the sale of the Shares pursuant
to this Agreement) on such day, the Net Proceeds to the Company and the compensation payable by the Company to the Agent under this Agreement
with respect to such sales.

 

(i)                 Settlement
for sales of Shares will occur on the second business day that is also a Trading Day following the trade date on which such sales are
made, unless another date shall be agreed to by the Company and the Agent (each such day, a “Delivery Date”). 
On each Delivery Date, the Shares sold through the Agent for settlement on such date shall be delivered by the Company to the Agent against
payment of the Net Proceeds from the sale of such Shares.  Settlement for all Shares shall be effected by book-entry delivery of
Shares to the Agent’s account at The Depository Trust Company against payment by the Agent of the Net Proceeds from the sale of
such Shares in same day funds delivered to an account designated by the Company.  If the Company or its transfer agent (if applicable)
shall default on its obligation to deliver Shares on any Delivery Date, the Company shall (A) indemnify and hold the Agent harmless
against any loss, claim or damage arising from or as a result of such default by the Company and (B) pay the Agent any commission
to which it would otherwise be entitled absent such default.  If the Agent breaches this Agreement by failing to deliver the applicable
Net Proceeds on any Delivery Date for Shares delivered by the Company, the Agent will pay the Company interest based on the effective
overnight federal funds rate until such Net Proceeds, together with such interest, have been fully paid.

 

(j)                 The
Company agrees that any offer to sell, any solicitation of an offer to buy, or any sales of Shares or any other equity security of
the Company shall only be effected by or through the Agent, from the period beginning one Regulation M Business Day prior to the
time when the first sale pursuant to a Placement Notice occurs, to the extent Regulation M is applicable, and continuing through the
time such Placement Notice is in effect; provided, however, that the foregoing limitation shall not apply to the exercise of any
option, warrant, right or any conversion privilege set forth in the instrument governing such security or any other security of the
Company.

 

    17

     

    

 

(k)                The
Company consents to the Agent trading in the Common Stock for the Agent’s own account and for the account of its clients at the
same time as sales of the Shares occur pursuant to this Agreement or pursuant to a Terms Agreement.

 

(l)                 The
Company acknowledges and agrees that (i) there can be no assurance that the Agent will be successful in selling Shares, (ii) the
Agent may not solicit any offers to buy the Shares, (iii) the Agent will incur no liability or obligation to the Company or any other
person or entity if it does not sell Shares for any reason other than a failure by the Agent to use its commercially reasonable efforts
consistent with its normal trading and sales practices to sell such Shares as required under this Section 2, subject
to the limitations and provisions in this Section 2 or as may otherwise be agreed to between the parties from time to
time and (iv) the Agent shall be under no obligation to purchase Shares on a principal basis pursuant to this Agreement, except as
otherwise agreed by the Agent and the Company in a Terms Agreement.

 

(m)               At
each Applicable Time, each Delivery Date and each Representation Date, the Company and the Bank shall be deemed to have affirmed each
representation, warranty, covenant and other agreement contained in this Agreement.

 

SECTION
3. ALTERNATIVE PLACEMENT.

 

(a)                 Notice
of Alternative Placement. If the Company wishes to issue and sell the Shares other than as set forth in Section 2 of
this Agreement (an “Alternative Placement”), it will notify the Agent of the proposed terms of such Alternative Placement.
If the Agent, acting as principal or agent, wishes to accept such proposed terms and the Company wishes to enter into an Alternative Placement
with the Agent (which it may decline to do for any reason in its sole discretion) or, following discussions with the Company wishes to
accept amended terms, then the Agent and the Company will enter into a Terms Agreement, setting forth the terms of such Alternative Placement. 

 

(b)                Execution
of Terms Agreement. The terms set forth in a Terms Agreement will not be binding on the Company or the Agent unless and until the
Company and the Agent have each executed such Terms Agreement accepting all of the terms of such Terms Agreement. In the event of a conflict
between the terms of this Agreement and the terms of a Terms Agreement, the terms of such Terms Agreement will control.

 

SECTION
4. COMPLIANCE WITH INSIDER TRADING POLICY; SECURITIES LAWS.

 

(a)                Notwithstanding
any other provision of this Agreement, (i) the Company shall not offer or sell, or request the offer or sale of, any Shares,
(ii) the Company, by notice to the Agent given by telephone (confirmed promptly by e-mail), shall cancel any instructions for
the offer or sale of Shares, and (iii) the Agent shall not be obligated to offer or sell any Shares, (x) unless otherwise
agreed to in writing by the parties hereto (which agreement may be contained in a Placement Notice or in such other instructions
provided by the Company to the Agent pursuant to Section 2(b)) during any period in which the Company’s
insider trading policy, as it exists on the date of this Agreement, would prohibit the purchases or sales of the Common Stock by its
officers or directors, (y) at any time or during any period that the Company is in possession of material non-public
information or (z) except as provided in Section 4(b) below, at any time from and including the date
(each, an “Announcement Date”) on which the Company shall issue a press release containing, or shall otherwise
publicly announce, its earnings, revenues or other results of operations (each, an “Earnings Announcement”)
through and including the time that is twenty-four (24) hours after the time that the Company files (a “Filing
Time”) a Quarterly Report on Form 10-Q or an Annual Report on Form 10-K that includes consolidated financial
statements as of and for the same period or periods, as the case may be, covered by such Earnings Announcement.  For purposes
of this Section 4(a) and Section 4(b) below, references to “twenty-four (24)
hours” shall exclude any hours in a day that is not a business day.

 

    18

     

    

 

(b)                If
the Company wishes to offer or sell Shares on any date during the period from and including an Announcement Date through and including
the time that is twenty-four (24) hours after the corresponding Filing Time, the Company shall (i) prepare and deliver to the Agent
(with a copy to counsel to the Agent) a Current Report on Form 8-K which shall include substantially the same financial and related
information as was set forth in the relevant Earnings Announcement (other than any earnings projections or similar forward-looking data)
(each, an “Earnings 8-K”), in form and substance reasonably satisfactory to the Agent, and obtain the consent of the
Agent to the filing thereof (such consent not to be unreasonably withheld or delayed), (ii) provide the Agent with the officers’
certificate and accountants’ letter called for by Section 5(o) and Section 5(q), respectively,
and (iii) file such Earnings 8-K with the Commission.  If the Company fully satisfies the requirements of clauses (i) through
(iii) of this Section 4(b), then the provisions of clause (ii) of Section 4(a) shall
not be applicable for the period from and after the time at which the foregoing conditions shall have been satisfied (or, if later, the
time that is twenty-four (24) hours after the time that the relevant Earnings Announcement was first publicly released) through and including
the time that is twenty-four (24) hours after the Filing Time of the relevant Quarterly Report on Form 10-Q or Annual Report on Form 10-K,
as the case may be.  For purposes of clarity, the parties hereto agree that (A) the delivery of any officers’ certificate
or accountants’ letter pursuant to this Section 4(b) shall not relieve the Company from any of its obligations
under this Agreement with respect to any such Quarterly Report on Form 10-Q or Annual Report on Form 10-K, as the case may be,
including, without limitation, the obligation to deliver officers’ certificates, accountants’ letters and legal opinions and
related letters as provided in Section 7 hereof, (B) this Section 4(b) shall in no way
affect the provisions of clause (x) of Section 4(a), which shall have independent application and (C) the provisions
of this Section 4(b) shall in no way affect the Company’s ability to file, subject to compliance with other
applicable provisions of this Agreement, Current Reports on Form 8-K relating to earnings or other matters.

 

SECTION 5.
COVENANTS.

 

(a)                 Compliance
with Securities Regulations and Commission Requests. The Company agrees to prepare the Prospectus in a form approved by the
Agent and to file such Prospectus pursuant to Rule 424(b) of the 1933 Act Regulations (without reliance on
Rule 424(b)(8) of the 1933 Act Regulations) not later than the Commission’s close of business on the second business
day following the execution and delivery of this Agreement, or, if applicable, such earlier time as may be required by
Rule 430B of the 1933 Act Regulations (or, if applicable, Rule 430A of the 1933 Act Regulations); to make no further
amendment or any supplement to the Registration Statement or Prospectus which shall be disapproved by the Agent promptly after
reasonable notice thereof; to advise the Agent, promptly after it receives notice thereof, of the time when any amendment to the
Registration Statement or any Rule 462(b) Registration Statement has been filed or becomes effective or any supplement to
the Prospectus or any amended Prospectus has been filed and to furnish the Agent with copies thereof; to advise the Agent, promptly
after it receives notice thereof, of the issuance by the Commission of any stop order or of any order preventing or suspending the
use of any Issuer Free Writing Prospectus or Prospectus, of the suspension of the qualification of the Shares for offering or sale
in any jurisdiction, of the initiation or threatening of any proceeding for any such purpose, or of any request by the Commission
for the amending or supplementing of the Registration Statement, any Issuer Free Writing Prospectus or Prospectus (in each case,
including any document incorporated or deemed to be incorporated by reference therein) or for additional information; and in the
event of the issuance of any stop order or of any order preventing or suspending the use of any Issuer Free Writing Prospectus or
Prospectus or suspending any such qualification, promptly to use its best efforts to obtain the withdrawal of such order.

 

    19

     

    

 

(b)                Continued
Compliance with Securities Laws. The Company will, during any period when the delivery of a prospectus is required in connection
with the offering or sale of Shares (including, without limitation, pursuant to Rule 173(d) of the 1933 Act Regulations), if
any event shall have occurred as a result of which the Prospectus as then amended or supplemented would include an untrue statement of
a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances
under which they were made, not misleading, or, if for any other reason it shall be necessary to amend or supplement the Prospectus (including,
without limitation, any document incorporated by reference therein) in order to comply with the 1933 Act or the 1934 Act, notify the Agent
and, upon its request, file such document and prepare and furnish without charge to the Agent as many copies as the Agent may from time
to time reasonably request of an amended or supplemented Prospectus (or incorporated document, as the case may be) that will correct such
statement or omission or effect such compliance.  Upon such notification, the Agent will cease selling the Shares on the Company’s
behalf pursuant to this Agreement and suspend the use of the Prospectus until such amendment or supplement is filed; provided, however,
that such suspension or termination shall not affect or impair the parties’ respective obligations with respect to the Shares sold
hereunder or which an investor has agreed to purchase but which has not been delivered by the Company and paid for by such investor as
contemplated hereby, prior to the giving of such notice.

 

(c)                 Issuer
Free Writing Prospectuses. The Company represents and agrees that, unless it obtains the prior written consent of the Agent,
and the Agent represents and agrees that, unless it obtains the prior written consent of the Company, it has not made and will not make
any offer relating to the Shares that would constitute an “issuer free writing prospectus,” as defined in Rule 433 of
the 1933 Act Regulations, or that would otherwise constitute a “free writing prospectus,” as defined in Rule 405 of the
1933 Act Regulations, required to be filed with the Commission.  Any such free writing prospectus consented to by the Company and
the Agent is hereinafter referred to as a “Permitted Free Writing Prospectus.”  The Company represents that it
has treated and agrees that it will treat each Permitted Free Writing Prospectus as an “issuer free writing prospectus,” as
defined in Rule 433, and has complied and will comply with the requirements of Rule 433 applicable to any Permitted Free Writing
Prospectus, including timely filing with the Commission where required, legending and record keeping.  The Company represents that
it has satisfied the conditions in Rule 433 to avoid a requirement to file with the Commission any electronic road show.

 

(d)                Blue
Sky Qualifications. Promptly from time to time, the Company will take such action as the Agent
may reasonably request to qualify the Shares for offering and sale under the securities laws of such states and other jurisdictions
as the Agent may reasonably request and to comply with such laws so as to permit the
continuance of sales and dealings therein in such jurisdictions for as long as may be necessary to complete the distribution of the Shares,
provided that in connection therewith the Company shall not be required to qualify as a foreign corporation or to file a general consent
to service of process in any jurisdiction. In each state or other jurisdiction in which the Shares have been so qualified, the Company
will file such statements and reports as may be required by the laws of such state or other jurisdiction to continue such qualification
in effect until the completion of the distribution of the Shares. The Company will also supply the Agent with such information as is
necessary for the determination of the legality of the Shares for investment under the laws of such jurisdiction as the Agent may reasonably
request

 

    20

     

    

 

(e)                Delivery
of Prospectuses.  Prior to 10:00 a.m., New York City time, on the New York Business Day next succeeding the date of this
Agreement during the period in which a prospectus is required to be delivered under the 1933 Act or the 1934 Act in connection with
any sale of Shares (including, without limitation, pursuant to Rule 173(d) of the 1933 Act Regulations), the Company will
furnish the Agent with copies of the Prospectus in New York City in such quantities as the Agent may from time to time reasonably
request, and, if the delivery of a prospectus is required at any time prior to the expiration of nine (9) months after the time
of issue of the Prospectus in connection with the offering or sale of the Shares and if at such time any event shall have occurred
as a result of which the Prospectus as then amended or supplemented would include an untrue statement of a material fact or omit to
state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they were
made when such Prospectus is delivered, not misleading, or, if for any other reason it shall be necessary during such period to
amend or supplement the Prospectus in order to comply with the 1933 Act or the 1933 Act Regulations, to notify the Agent and upon
its request to prepare and furnish without charge to the Agent and to any dealer in securities as many copies as the Agent may from
time to time reasonably request of an amended Prospectus or a supplement to the Prospectus which will correct such statement or
omission or effect such compliance, and in case the Agent is required to deliver a prospectus in connection with sales of any of the
Shares at any time nine (9) months or more after the time of issue of the Prospectus, upon its request, to prepare and deliver
to the Agent as many copies as the Agent may request of an amended or supplemented Prospectus complying with
Section 10(a)(3) of the 1933 Act.

 

(f)                 Rule
158. The Company will timely file such reports pursuant to the 1934 Act as are necessary in order to make generally available
(which may be satisfied by filing with the Commission pursuant to EDGAR) to its securityholders as soon as practicable an earnings statement
for the purposes of, and to provide to the Agent the benefits contemplated by, the last paragraph of Section 11(a) of the 1933 Act.

 

(g)                Reporting
Requirements. The Company, during the period in which a prospectus is (or, but for the exception afforded by Rule 172, would be) required
by the 1933 Act to be delivered in connection with any offer or sale of Shares, will file all documents required to be filed with the
Commission pursuant to the 1934 Act within the time periods required by, and meeting the requirements of, the 1934 Act and the 1934 Act
Regulations. Additionally, the Company shall report the use of the net proceeds from the sale of any Shares as may be required under the
1933 Act and the 1933 Act Regulations, including, if applicable, Rule 463 of the 1933 Act Regulations.

 

(h)                Furnishing
of Securities Filings.

 

(i)       During
a period of three years from the effective date of the Registration Statement, the Company will furnish to the holders of the Shares as
soon as practicable after the end of each fiscal year an annual report (including balance sheets and statements of income, shareholders’
equity and cash flows of the Company and its consolidated Subsidiaries certified by independent public accountants) and, as soon as practicable
after the end of each of the first three quarters of each fiscal year (beginning with the fiscal quarter ending after the effective date
of the Registration Statement), to make available to such holders consolidated summary financial information of the Company and its Subsidiaries
for such quarter in reasonable detail; provided that if the Company files an annual report on Form 10-K or quarterly report on Form 10-Q
by means of EDGAR, the Company shall be deemed to have furnished such report to such holders in compliance with the requirements of this
section.

 

    21

     

    

 

(ii)       During
a period of three years from the effective date of the Registration Statement, the Company will furnish to the Agent copies of all
reports or other communications (financial or other) furnished to holders of the Shares, and to deliver to the Agent (i) as
soon as they are available, copies of any reports and financial statements furnished to or filed with the Commission or any national
securities exchange on which any class of securities of the Company is listed and (ii) subject to an appropriate
confidentiality agreement, such additional information concerning the business and financial condition of the Company as the Agent
may from time to time reasonably request (such financial statements to be on a consolidated basis to the extent the accounts of the
Company and its Subsidiaries are consolidated in reports furnished to its shareholders generally or to the Commission); provided
that if the Company files any such reports or other communications of the type contemplated by clauses (i) or (ii) above
with the Commission and such report or materials are or will become available on EDGAR, the Company shall be deemed to have
furnished such report or other communications to the Agent in compliance with the requirements of this section.

 

(i)                 Use
of Proceeds. The Company will use the net proceeds received by it from the sale of the Shares pursuant to this Agreement in
the manner specified in each of the General Disclosure Package and the Prospectus under the caption “Use of Proceeds”.

 

(j)                 Rules
462 Filings. If the Company elects to rely on Rule 462(b) of the 1933 Act Regulations, the Company shall file a Rule 462(b) Registration
Statement with the Commission in compliance with Rule 462(b) of the 1933 Act Regulations by 10:00 p.m., Washington, D.C. time,
on the date of this Agreement, and the Company shall at the time of filing either pay to the Commission the filing fee for the Rule 462(b) Registration
Statement or give irrevocable instructions for the payment of such fee pursuant to Rule 111(b) of the 1933 Act Regulations.

 

(k)                 Listing
Requirements. The Company will comply with all requirements of the Nasdaq Capital Market with respect to the issuance of the
Shares and will use its reasonable best efforts to cause the Shares to be listed on the Nasdaq Capital Market and will file with the Nasdaq
Capital Market all documents and notices required by the Nasdaq Capital Market of companies that have securities that are traded on the
Nasdaq Capital Market to effect such listing.

  

(l)                 Due
Diligence Review. The Company will reasonably cooperate on a timely basis with any reasonable due diligence request from, or
review conducted by, the Agent or its counsel from time to time in connection with offers and sales of Shares, including, without limitation,
and upon reasonable notice, providing information and making available documents and appropriate corporate officers, during regular business
hours and at the Company’s principal offices and/or by telephone, as the Agent or its counsel may reasonably request (each such
process, a “Due Diligence Process”).

 

(m)               Filing
of Use of Amendments and Supplements. Upon the commencement of the period during which Shares are to be sold as
instructed by the Company under the applicable Placement Notice (as amended by the corresponding Acceptance if applicable) given
hereunder and during the pendency thereof, promptly after each (i) date the Registration Statement or the Prospectus shall be
amended or supplemented (other than (1) by an amendment or supplement providing solely for the determination of the terms of
the Shares, (2) in connection with the filing of any report or other document under Section 13, 14 or 15(d) of the
1934 Act, or (3) by a prospectus supplement relating to the offering of other securities (including, without limitation, other
shares of Common Stock)) (each such date, a “Registration Statement Amendment Date”) and (ii) date on which
the Company shall file (x) an Annual Report on Form 10-K, Quarterly Report on Form 10-Q or Earnings 8-K or
(y) an amendment to any such document (each such date, a “Company Periodic Report Date”) (each of the date
of the commencement of the offering of Shares under this Agreement and each Registration Statement Amendment Date and Company
Periodic Report Date is hereinafter referred to as a “Representation Date”), the Company will furnish or cause to
be furnished to the Agent (with a copy to counsel to the Agent) a certificate dated such Representation Date (or, in the case of an
amendment or supplement to the Registration Statement or the Prospectus (including, without limitation, by the filing of an Annual
Report on Form 10-K, Quarterly Report on Form 10-Q or Earnings 8-K or any amendment thereto), the date of the
effectiveness of such amendment to the Registration Statement or the date of filing with the Commission of such supplement or any
such Form 10-K, Form 10-Q, Earnings 8-K or amendment thereto, as the case may be), in a form reasonably satisfactory to
the Agent to the effect that the statements contained in the certificates referred to in Section 7(i) and
(j) of this Agreement which was last furnished to the Agent are true and correct as of the date of such certificate as
though made at and as of the date of such certificate (except that such statements shall be deemed to relate to the Registration
Statement, the Prospectus and the General Disclosure Package as amended and supplemented to the date of such certificate) or, in
lieu of such certificates, a certificate of the same tenor as the certificates referred to in Section 7(i) and (j),
but modified as necessary to relate to the Registration Statement, the Prospectus and the General Disclosure Package as amended and
supplemented to the date of such certificate.  As used in this paragraph, to the extent there shall be an Applicable Time on or
following the applicable Representation Date, “promptly” shall be deemed to be on or prior to the next succeeding
Applicable Time.

 

    22

     

    

 

(n)                Delivery
of Future Opinions and Letters of Counsel. Upon the commencement of the period during which Shares are to be sold as instructed
by the Company under the applicable Placement Notice (as amended by the corresponding Acceptance if applicable) given hereunder and during
the pendency thereof, and promptly after a Representation Date, the Company will furnish or cause to be furnished to the Agent (with a
copy to counsel to the Agent), unless the Agent otherwise agrees in writing, the written opinion and letter of counsel to the Company,
dated such Representation Date (or, in the case of an amendment or supplement to the Registration Statement or the Prospectus (including,
without limitation, by the filing of an Annual Report on Form 10-K or Quarterly Report on Form 10-Q or any amendment thereto),
the date of the effectiveness of such amendment to the Registration Statement or the date of filing with the Commission of such supplement
or any such Form 10-K, Form 10-Q or amendment thereto, as the case may be), in a form and substance reasonably satisfactory
to the Agent and its counsel, of the same tenor as the opinions and letters referred to in Section 7(c) of this
Agreement, but modified as necessary to relate to the Registration Statement, the Prospectus and the General Disclosure Package as amended
and supplemented to the date of such opinion and letter or, in lieu of such opinion and letter, counsel last furnishing any such opinion
and letter to the Agent shall furnish the Agent with a letter substantially to the effect that the Agent may rely on such counsel’s
last opinion and letter to the same extent as though each were dated the date of such letter authorizing reliance (except that statements
in such last opinion and letter shall be deemed to relate to the Registration Statement, the Prospectus and the General Disclosure Package
as amended and supplemented to the date of such letter authorizing reliance).  As used in this paragraph, to the extent there shall
be an Applicable Time on or following the applicable Representation Date, “promptly” shall be deemed to be on or prior to
the next succeeding Applicable Time.  Solely for the purposes of this paragraph, the term “Representation Date” shall
not include the date of filing of any Earnings 8-K or any amendment thereto.

 

(o)                Delivery
of Future Accountant Letters. Upon the commencement of the period during which Shares are to be sold as instructed by
the Company under the applicable Placement Notice (as amended by the corresponding Acceptance if applicable) given hereunder and during
the pendency thereof, and promptly after a Representation Date, the Company will cause BDO LLP to furnish to the Agent (with a copy to
counsel to the Agent), unless the Agent otherwise agrees in writing, a letter, dated such Representation Date (or, in the case of an amendment
or supplement to the Registration Statement or the Prospectus (including, without limitation, by the filing of an Annual Report on Form 10-K,
Quarterly Report on Form 10-Q, Earnings 8-K or any amendment thereto), the date of the effectiveness of such amendment to the
Registration Statement or the date of filing with the Commission of such supplement or any such Form 10-K, Form 10-Q, Earnings
8-K or any amendment thereto, as the case may be), in form reasonably satisfactory to the Agent and its counsel, of the same tenor as
the letter referred to in Section 7(d) hereof, but modified as necessary to relate to the Registration Statement,
the Prospectus and the General Disclosure Package as amended and supplemented to the date of such letter.  As used in this paragraph,
to the extent there shall be an Applicable Time on or following the applicable Representation Date, “promptly” shall be deemed
to be on or prior to the next succeeding Applicable Time.

 

    23

     

    

 

(p)                No
Stabilization; Manipulation. The Company will not take, directly or indirectly, any action designed to or that might be reasonably
expected to cause or result in stabilization or manipulation of the price of any securities of the Company, whether to facilitate the
sale or resale of the Shares or otherwise, and the Company will, and shall use its commercially reasonable efforts to cause each of its
affiliates to, comply with all applicable provisions of Regulation M with respect to any securities of the Company.

 

(q)                Compliance
with Regulation M. During the pendency of any Placement Notice (as amended by the corresponding Acceptance, if applicable)
given hereunder, (i) the Company shall provide the Agent notice no less than one Regulation M Business Day, to the extent Regulation
M is applicable, before it or any of its subsidiaries or any person acting on their behalf, directly or indirectly, offers to sell, contracts
to sell, sells, grants any option to sell or otherwise disposes of any Common Stock (other than Placement Shares offered pursuant to the
provisions of this Agreement) or securities convertible into or exchangeable for Common Stock, warrants or any rights to purchase or acquire
Common Stock; provided, that no such restriction shall apply in connection with (1) the issuance, grant or sale of Common Stock,
options to purchase Common Stock, restricted stock units for Common Stock or Common Stock issuable upon the exercise of options or other
equity awards pursuant to any stock option, stock bonus or other stock or compensatory plan or arrangement described in the Prospectus
or (2) the issuance or sale of Common Stock pursuant to any dividend reinvestment plan that the Company may adopt from time to time,
provided the implementation of such is disclosed to the Agent in advance; (ii) the Company shall not, and shall cause any affiliated
purchasers (as defined in Rule 100 of Regulation M of the 1933 Act Regulations) of the Company to not, bid for, purchase or induce
any other persons to bid for or purchase Shares; and (iii) the Company shall provide the Agent notice no less than one Regulation
M Business Day, to the extent Regulation M is applicable, before it or any of its subsidiaries or affiliates or any person acting on their
behalf engages in any special selling efforts or selling methods with regard to Shares, including but not limited to presenting at any
investor conference or other similar meeting where potential investors may be present.

 

SECTION 6. PAYMENT OF EXPENSES.    The
Company covenants and agrees with the Agent that the Company will pay or cause to be paid the following, whether or not the transactions
contemplated herein are completed (regardless of whether the sale of the Shares is consummated): (i) the reasonable out-of-pocket expenses
incurred by the Agent in connection with its engagement, including without limitation, outside legal fees and expenses, marketing, syndication
and travel expenses; (ii) the cost of obtaining all securities and bank regulatory approvals, including any required FINRA fees, including
the filing fees incident thereto; (iii) all fees and disbursements of the Company’s counsel and accountants in connection with the
registration of the Shares under the 1933 Act and all other expenses in connection with the preparation, printing and filing of amendments
and supplements thereto and the mailing and delivering of copies thereof to the Agent and dealers; (iv) all expenses in connection with
the qualification of the Shares for offering and sale under state securities as provided in Section 5(d) hereof, including the
fees and disbursements of counsel for the Agent in connection with such qualification and in connection with the Blue Sky survey; (v)
the cost of printing or reproducing this Agreement, the Blue Sky survey, closing documents (including any compilations thereof) and any
other documents in connection with the offering, purchase, sale and delivery of the Shares; (vi) the cost and charges of any transfer
agent or registrar; (vii); and (viii) all other costs and expenses incident to the performance of the Company’s obligations hereunder
which are not otherwise specifically provided for in this Section 6.

 

    24

     

    

 

SECTION 7. CONDITIONS
OF AGENTS’ OBLIGATIONS.     The obligations of the Agent hereunder shall be subject, in its sole discretion, to the
condition that all representations and warranties and other statements of the Company herein or in certificates of any officer of
the Company delivered pursuant to the provisions hereof are true and correct as of the time of the execution of this Agreement, and
as of each Representation Date, Applicable Time and Delivery Date, to the condition that the Company shall have performed all of its
obligations hereunder theretofore to be performed, and the following additional conditions:

 

(a)                Effectiveness
of Registration Statement and Fling of Prospectus. The Prospectus containing the Rule 430B Information shall have been filed
with the Commission pursuant to Rule 424(b) of the 1933 Act Regulations in the manner and within the time period required by
Rule 424(b) of the 1933 Act Regulations (without reliance on Rule 424(d)(8) of the 1933 Act Regulations) and in accordance
with Section 5(a) hereof; the Registration Statement, including any Rule 462(b) Registration Statement,
has become effective and no stop order suspending the effectiveness of the Registration Statement or any part thereof shall have been
issued and no proceeding for that purpose shall have been initiated or threatened by the Commission; and all requests for additional information
on the part of the Commission shall have been complied with to the reasonable satisfaction of the Agent; and FINRA shall have raised no
objection to the fairness and reasonableness of the sales agency terms and arrangements.

 

(b)                Opinion
of Counsel to the Company. The Agent shall have received the opinion of Luse Gorman PC, counsel for the Company, in form and
substance reasonably satisfactory to counsel for the Agent. Such counsel may also state that, insofar as either such opinion involves
factual matters, they have relied, to the extent they deem proper, upon certificates of officers of the Company and its subsidiaries and
certificates of public officials.

 

(c)                Opinion
of Counsel for the Agent. The Agent shall have received the opinion of Kilpatrick Townsend & Stockton LLP, counsel for
the Agent. The opinion shall address the matters as the Agent may reasonably request. In giving such opinion such counsel may rely, as
to all matters governed by the laws of jurisdictions other than the law of the State of New York and the federal law of the United States,
upon the opinions of counsel satisfactory to the Agent. Such counsel may also state that, insofar as such opinion involves factual matters,
they have relied, to the extent they deem proper, upon certificates of officers of the Company and its subsidiaries and certificates of
public officials.

 

(d)                Accountant’s
Comfort Letter. On each date specified in Section 5(q), BDO LLP shall have furnished to the Agent a letter or letters,
dated the respective dates of delivery thereof, in form and substance satisfactory to the Agent, containing statements and information
of the type ordinarily included in accountants “comfort letters” to the Agent with respect to the financial statements of
the Company and certain financial information contained in the Registration Statement, the General Disclosure Package and the Prospectus,
provided that the letter delivered as of the Closing Time shall use a “cut-off” date no more than three business days prior
to the Closing Time.

 

(e)                 No
Material Change. (i) Neither the Company nor any of its subsidiaries shall have sustained since the date of the latest
audited financial statements included in each of the Registration Statement, General Disclosure Package and the Prospectus any loss
or interference with its business from fire, explosion, flood or other calamity, whether or not covered by insurance, or from any
labor dispute or court or governmental or regulatory action, order or decree, otherwise than as set forth or contemplated in the
Registration Statement, the General Disclosure Package and the Prospectus, and (ii) since the respective dates as of which
information is given in each of the Registration Statement, the General Disclosure Package and the Prospectus there shall not have
been any change in the capital stock or debt of the Company or decreases in the total assets, allowance for loan losses or total
deposits of the Company or any of its subsidiaries or any change in or affecting the general affairs, management, financial
position, capital adequacy for regulatory purposes, shareholders’ equity or results of operations of the Company and its
subsidiaries, otherwise than as set forth or contemplated in the Registration Statement, the General Disclosure Package and the
Prospectus, or their business affairs, business prospects or regulatory affairs, the effect of which, in any such case described in
clause (i) or (ii), is in the judgment of the Agent so material and adverse as to make it impracticable or inadvisable to proceed
with the public offering or the delivery of the Shares being delivered at such Applicable Time or Delivery Date, as the case may be,
on the terms and in the manner contemplated in each of the General Disclosure Package and the Prospectus.

 

    25

     

    

 

(f)
                 No Adverse Event. On or after
the date hereof there shall not have occurred any of the following: (i) a suspension or material limitation in trading in
securities generally on the New York Stock Exchange or on the NASDAQ; (ii) a suspension or material limitation in trading in
the Company’s securities on the NASDAQ; (iii) a general moratorium on commercial banking activities declared by either
federal or New York authorities or a material disruption in commercial banking or securities settlement or clearance services in the
United States; (iv) the outbreak or escalation of hostilities involving the United States or the declaration by the United
States of a national emergency or war; or (v) the occurrence of any other calamity or crisis or any change in financial,
political or economic conditions in the United States or elsewhere, including, without limitation, as a result of terrorist
activities occurring after the date hereof, if the effect of any such event specified in clause (iv) or (v), in the reasonable
judgment of the Agent makes it impracticable or inadvisable to proceed with the public offering or the delivery of the Shares being
delivered at the Closing Time on the terms and in the manner contemplated in the Prospectus. .

 

(g)                 Registration
of Common Stock. The Common Stock (including the Shares) is and continues to be registered pursuant to Section 12(b) of
the 1934 Act and is listed on the Nasdaq Capital Market, and the Company has taken no action designed to, or likely to have the effect
of, terminating the registration of the Common Stock under the 1934 Act or delisting the Common Stock from the Nasdaq Capital Market,
nor has the Company received any notification that the Commission or FINRA is contemplating terminating such registration or listing.

 

(h)                Officers’
Certificate – Company. The Agent shall have received a certificate of the Chief Executive Officer of the Company and of the
Chief Financial Officer of the Company on each Representation Date specified in Section 5(o) to the effect that (i) the representations
and warranties in Section 1(a) hereof are true and correct with the same
force and effect as though made at and as of each Representation Date, (ii) the Company has complied with all agreements and satisfied
all conditions on its part to be performed or satisfied at or prior to each Representation Date, and (iii) no stop order suspending the
effectiveness of the Registration Statement has been issued and no proceedings for that purpose have been instituted or are pending or
are to their knowledge contemplated by the Commission.

 

(i)                 Officers’
Certificate – Bank. The Agent shall have received a certificate from the President of the Bank and of the Chief
Financial Officer of the Bank or Chief Accounting Officer of the Bank, dated as of each Representation Date to the effect that
the representations and warranties in Section 1(b) hereof are true and correct
with the same force and effect as though made at and as of each Representation Date.

 

(k)                Placement
Notice. The Company shall have furnished or cause to be furnished promptly to the Agent a Placement Notice or such other
instructions provided pursuant to Section 2(b) as requested by the Agent;

 

(l)                  Date
of Commencement of Sales. The Company and the Agent hereby agree that the date of commencement of sales under this Agreement
shall be the date the Company and the Agent mutually agree (which may be later than the date of this Agreement).

 

    26

     

    

 

SECTION 8. INDEMNIFICATION.

 

(a)                 Indemnification
of Agent. The Company and the Bank, jointly and severally, will indemnify and hold harmless the Agent, each person, if any, who controls
the Agent within the meaning of Section 15 of the 1933 Act or Section 20 of the 1934 Act, and their respective partners, directors,
officers, employees and agents and each affiliate of the Agent within the meaning of Rule 405 against any losses, claims, damages or liabilities,
joint or several, to which the Agent may become subject, under the 1933 Act or otherwise, insofar as such losses, claims, damages or liabilities
(or actions in respect thereof) arise out of or are based upon an untrue statement or alleged untrue statement of a material fact contained
in any Issuer Free Writing Prospectus, any preliminary prospectus, the Registration Statement, the General Disclosure Package, the Prospectus,
or any amendment or supplement thereto, or arise out of or are based upon the omission or alleged omission to state therein a material
fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made,
not misleading, and will reimburse the Agent for any legal or other expenses reasonably incurred by the Agent in connection with investigating
or defending any such action or claim as such expenses are incurred; provided, however, that the Company and the Bank shall
not be liable in any such case to the extent that any such loss, claim, damage or liability arises out of or is based upon an untrue statement
or alleged untrue statement or omission or alleged omission made in any Issuer Free Writing Prospectus, any preliminary prospectus, the
Registration Statement, the General Disclosure Package, the Prospectus or any such amendment or supplement in reliance upon and in conformity
with written information furnished to the Company by the Agent expressly for use therein. The Company, the Bank and the Agent hereby acknowledge
and agree that the only information that the Agent have furnished to the Company consists solely of the information described as such
in subsection (b) below. Notwithstanding the foregoing, the indemnification provided for by the Bank in this paragraph shall
be limited with respect to the Bank to the extent necessary if (a) a Governmental Entity having jurisdiction over the Bank by written
communication addressed to the Bank or its board of directors, including in connection with any examination of the Bank, informs the Bank
or its board of directors that such Governmental Entity has determined that such indemnification violates Sections 23A or 23B of the Federal
Reserve Act, as amended, or another law, rule, regulation or policy applicable to the Bank or the Company, (b) a Governmental Entity notifies
the Bank that this indemnification would result in an adverse impact on the Bank’s examination ratings, (c) such indemnification
would give rise to civil money penalties or other sanctions or (d) the Bank determines, upon the written advice of counsel, that payment
of any indemnification hereunder by the Bank would violate any law, rule, regulation or policy applicable to the Bank or the Company.
The Company and the Bank agree to notify the Agent immediately upon receipt of such written advisement or notice. The Agent agree to cooperate
with the Company in implementing any modification required by the foregoing.

 

    27

     

    

 

(b)                 Indemnification
of Company, Directors and Officers. Each Agent severally agrees to indemnify and hold harmless the Company, its officers,
directors and each person, if any, who controls the Company, within the meaning of Section 15 of the 1933 Act or
Section 20 of the 1934 Act, against any losses, claims, damages or liabilities to which the Company may become subject, under
the 1933 Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or
are based upon an untrue statement or alleged untrue statement of a material fact contained in the Registration Statement (or any
amendment thereto), including the Rule 430A Information, the General Disclosure Package, any preliminary prospectus, any Issuer Free
Writing Prospectus, any Written Testing-the-Waters Communication, the Prospectus (or any amendment or supplement thereto),
including any roadshow or investor presentations made to investors by the Company (whether in person or electronically) in reliance
upon and in conformity with the Agent Information, but only to the extent, that such untrue statement or alleged untrue statement or
omission or alleged omission was made in any Registration Statement (or any amendment thereto), including the Rule 430A Information,
the General Disclosure Package, any preliminary prospectus, any Issuer Free Writing Prospectus, any
Written Testing-the-Waters Communication, the Prospectus (or any amendment or supplement thereto) or any roadshow or
investor presentations made to investors by the Company (whether in person or electronically), in reliance upon and in conformity
with written information furnished to the Company by the Agent expressly for use therein (provided, however, that the Company and
the Agent hereby acknowledge and agree that the only such information that the Agent has furnished to the Company consists solely of
Agent Information and will reimburse the Company for any legal or other expenses reasonably incurred by the Company in connection
with investigating or defending any such action or claim as such expenses are incurred).

 

(c)
                Actions against Parties;
Notification. Promptly after receipt by an indemnified party under subsection (a) or (b)  above of notice of the
commencement of any action, such indemnified party shall, if a claim in respect thereof is to be made against the indemnifying party
under such subsection, notify the indemnifying party in writing of the commencement thereof, but the omission so to notify the
indemnifying party shall not relieve it from any liability that it may have to any indemnified party otherwise than under such
subsection, unless the indemnifying party has been prejudiced thereby. In case any such action shall be brought against any
indemnified party and it shall notify the indemnifying party of the commencement thereof, the indemnifying party shall be entitled
to participate therein and, to the extent that it shall wish, jointly with any other indemnifying party similarly notified, to
assume the defense thereof, with counsel reasonably satisfactory to such indemnified party (who shall not, except with the consent
of the indemnified party which consent shall not be unreasonably withheld, conditioned or delayed, be counsel to the indemnifying
party), provided, however, if the defendants in any such action include both the indemnified party and the indemnifying party and
the indemnified party shall have reasonably concluded that a conflict may arise between the positions of the indemnifying party and
the indemnified party in conducting the defense of any such action or that there may be legal defenses available to its and/or other
indemnified parties which are different from or additional to those available to the indemnifying party, the indemnified party or
parties shall have the right to select separate counsel to assume such legal defenses of such indemnified party or parties (but not
to control the defense of such action as to the indemnifying party) and to otherwise participate in the defense of such action on
behalf of such indemnified party or parties, and, after notice from the indemnifying party to such indemnified party of its election
so to assume the defense thereof, the indemnifying party shall not be liable to such indemnified party under such subsection for any
legal expenses of other counsel or any other expenses, in each case subsequently incurred by such indemnified party, in connection
with the defense thereof other than reasonable costs of investigation unless (i) the indemnified party shall have employed
separate counsel in accordance with the proviso to the preceding sentence (it being understood, however, that the indemnifying party
shall not be liable for the fees and expenses of more than one separate counsel (together with, to the extent necessary in the
circumstances, one separate local counsel in the jurisdiction in which such action is pending) to represent all indemnified parties,
approved by the indemnifying party) or (ii) the indemnifying party shall not have employed counsel satisfactory to the
indemnified party within a reasonable time after notice of commencement of the action, in each of which cases the fees and expenses
of one counsel for the indemnified party or parties (in addition to local counsel) shall be at the expense of the indemnifying
party. The indemnifying party under this Section 8 shall not be liable for any settlement or compromise of or agreed
judgment in any proceedings effected or agreed to without its prior express written consent, but if any such proceeding is settled
or compromised, or an agreed judgment is entered into, with such consent or if there be a final judgment (other than an agreed
judgment) rendered in favor of the plaintiff, the indemnifying party agrees to indemnify the indemnified party against any loss,
claim, damage, liability or expense by reason of such settlement, compromise, agreed judgment or other judgment. No indemnifying
party shall, without the written consent of the indemnified party, effect the settlement or compromise of, or consent to the entry
of any judgment with respect to, any pending or threatened action or claim in respect of which indemnification or contribution may
be sought hereunder (whether or not the indemnified party is an actual or potential party to such action or claim) unless such
settlement, compromise or judgment (i) includes an unconditional release of the indemnified party from all liability arising
out of such action or claim and (ii) does not include a statement as to or an admission of fault, culpability or a failure to
act, by or on behalf of any indemnified party.

 

    28

     

    

 

(d)                Contribution.
If the indemnification provided for in this Section 8 is unavailable to or insufficient to hold harmless an indemnified party
under subsection (a) or (b) above in respect of any losses, claims, damages or liabilities (or actions in respect thereof) referred
to therein, then each indemnifying party shall contribute to the amount paid or payable by such indemnified party as a result of such
losses, claims, damages or liabilities (or actions in respect thereof) in such proportion as is appropriate to reflect the relative benefits
received by the Company on the one hand and the Agent on the other from the offering of the Shares. If, however, the allocation provided
by the immediately preceding sentence is not permitted by applicable law, then each indemnifying party shall contribute to such amount
paid or payable by such indemnified party in such proportion as is appropriate to reflect not only such relative benefits but also the
relative fault of the Company on the one hand, and the Agent, on the other hand, in connection with the statements or omissions which
resulted in such losses, claims, damages or liabilities (or actions in respect thereof), as well as any other relevant equitable considerations.
The relative benefits received by the Company, on the one hand, and the Agent, on the other, shall be deemed to be in the same proportion
as the total net proceeds from the offering (before deducting expenses) received by the Company bears to the total discounts and commissions
received by the Agent, in each case as set forth in the table on the cover page of the Prospectus. The relative fault shall be determined
by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission
to state a material fact relates to information supplied by the Company, on the one hand, or the Agent, on the other, and the parties’
relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. The Company, the Bank,
and the Agent agree that it would not be just and equitable if contributions pursuant to this subsection (d) were determined by pro
rata allocation or by any other method of allocation which does not take account of the equitable considerations referred to above
in this subsection (d). The amount paid or payable by an indemnified party as a result of the losses, claims, damages or liabilities (or
actions in respect thereof) referred to above in this subsection (d) shall be deemed to include any legal or other expenses reasonably
incurred by such indemnified party in connection with investigating or defending any such action or claim.

 

Notwithstanding the provisions
of this subsection (d), the Agent shall not be required to contribute any amount in excess of the amount by which the total price at which
the Shares underwritten by it and distributed to the public were offered to the public exceeds the amount of any damages which the Agent
has otherwise been required to pay by reason of any such untrue or alleged untrue statement or omission or alleged omission. No person
guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the 1933 Act) shall be entitled to contribution from
any person who was not guilty of such fraudulent misrepresentation.

 

For purposes of this Section 8,
each officer and employee of the Agent and each person, if any, who controls the Agent within the meaning of the 1933 Act and the 1934
Act shall have the same rights to contribution as the Agent, and each director of the Company, each officer of the Company who signed
the Registration Statement, and each person, if any, who controls the Company with the meaning of the 1933 Act and the 1934 Act shall
have the same rights to contribution as the Company.

 

Notwithstanding the
foregoing, the contribution obligation of the Bank in this paragraph shall be limited with respect to the Bank to the extent
necessary if (a) a Governmental Entity having jurisdiction over the Bank by written communication addressed to the Bank or its board
of directors, including in connection with any examination of the Bank, informs the Bank or its board of directors that such
Governmental Entity has determined that such contribution violates Sections 23A or 23B of the Federal Reserve Act, as amended, or
another law, rule, regulation or policy applicable to the Bank or the Company, (b) a Governmental Entity notifies the Bank that any
contribution would result in an adverse impact on the Bank’s examination ratings, (c) such contribution would give rise to
civil money penalties or other sanctions or (d) the Bank determines, upon the written advice of counsel, that any contribution made
by the Bank hereunder would violate any law, rule, regulation or policy applicable to the Bank or the Company.

 

    29

     

    

 

(e)                Liability.
The obligations of the Company and the Bank under this Section 8 shall be in addition to any liability which the Company and
the Bank may otherwise have and shall extend, upon the same terms and conditions, to each person, if any, who controls (within the meaning
of the 1933 Act) an Agent, or any of the respective partners, directors, officers and employees of an Agent or any such controlling person.
The obligations of an Agent under this Section 8 shall be in addition to any liability which such Agent may otherwise have
and shall extend, upon the same terms and conditions, to each person, if any, who controls (within the meaning of the 1933 Act) the Company
or any of the directors and officers of the Company or any such controlling person.

 

(g)               Remedies
Not Exclusive. The remedies provided for in this Section 8 are not exclusive and shall not limit any rights or remedies
which may otherwise be available to an indemnified party at law or in equity.

 

SECTION 9. TERMINATION
OF AGREEMENT.

 

(a)                 Termination
by Action of the Parties. Either Party may terminate this Agreement in its sole discretion by giving written notice as hereinafter
specified or otherwise by mutual agreement of the Parties. Any such termination shall be without liability of any party to any other party
except that (i) with respect to any pending sale through the Agent for the Company, the obligations of the Company, including in
respect of compensation of the Agent, shall remain in full force and effect notwithstanding such termination; and (ii) the representations
and warranties in Section 1 and the provisions of Sections 6, 8, 11, 12, 13, 14, and 15 of this Agreement shall
survive such termination.

 

(b)                 Termination
Upon Sale of Shares. This Agreement shall remain in full force and effect unless terminated pursuant to Section 9(a) 
and will automatically terminate following the sale of the Shares having an aggregate gross sales price of $20.0 million.

 

(c)                  Effective
Date of Termination. Any termination of this Agreement shall be effective on the date specified in such notice of termination or the
date mutually agreed by the parties, as the case may be; provided, that such termination shall not be effective until the close of business
on the date of receipt of such notice by the Agent or the Company, or the date mutually agreed by the parties, as the case may be. If
such termination shall occur prior to the Delivery Date for any sale of Stock, such sale shall settle in accordance with the provisions
of Section 2(i) hereof.

 

SECTION 10. REPRESENTATIONS,
WARRANTIES AND AGREEMENTS TO SURVIVE. The respective indemnities, agreements, representations, warranties and other statements
of the Company and the Agent, as set forth in this Agreement or made by or on behalf of them, respectively, pursuant to this Agreement,
shall remain in full force and effect, regardless of any investigation (or any statement as to the results thereof) made by or on behalf
of the Agent or any controlling person of the Agent, or the Company, or any officer or director or controlling person of the Company,
and shall survive delivery of and payment for the Shares.

 

    30

     

    

 

SECTION
11. NO ADVISORY OR FIDUCIARY RELATIONSHIP. The Company acknowledges and agrees that (i) the purchase and
sale of the Shares pursuant to this Agreement, including the determination of the public offering price of the Shares and any
related discounts and commissions, is an arm’s-length commercial transaction between the Company, on the one hand, and the
Agent, on the other hand, and the Company is capable of evaluating and understanding and understands and accepts the terms, risks
and conditions of the transactions contemplated by this Agreement, (ii) in connection with the offering contemplated hereby and
the process leading to such transaction the Agent is and has been acting solely as principal and is not the agent or fiduciary of
the Company, its Subsidiaries, or the Company’s shareholders, creditors, employees or any other third party, (iii) the
Agent has not assumed nor will it assume an advisory or fiduciary responsibility in favor of the Company or its Subsidiaries with
respect to the offering contemplated hereby or the process leading thereto (irrespective of whether the Agent has advised or is
currently advising the Company or its Subsidiaries on any other matters) and the Agent has no obligation to the Company or its
Subsidiaries with respect to the offering contemplated hereby except the obligations expressly set forth in this Agreement,
(iv) the Agent and its respective affiliates may be engaged in a broad range of transactions that involve interests that differ
from those of the Company or its Subsidiaries and the Agent has no obligation to disclose such interests and transactions to the
Company by virtue of any fiduciary, advisory or agency relationship, (v) the Company and its Subsidiaries waive, to the fullest
extent permitted by law, any claims the Company may have against the Agent for breach of fiduciary duty or alleged breach of
fiduciary duty and agree that the Agent shall not have any liability (whether direct or indirect) to the Company or its Subsidiaries
in respect of such a fiduciary duty claim or to any person asserting a fiduciary duty claim on behalf of or in right of the Company,
including shareholders, employees or creditors of the Company, and (vi) the Agent has not provided any legal, accounting,
regulatory or tax advice with respect to the offering contemplated hereby and the Company and the Bank consulted their own legal,
accounting, regulatory and tax advisors to the extent they deemed appropriate.

 

SECTION
12. NOTICES.  All statements, requests, notices and agreements hereunder shall be in writing, and if to the Agent
shall be delivered or sent by mail, overnight delivery service or facsimile transmission to the Agent at Piper Sandler & Co.,
1251 Avenue of the Americas, 6th Floor, New York, New York 10020, Attention: General Counsel, with a copy to Kilpatrick
Townsend & Stockton LLP, 607 14th Street, NW, Suite 900, Washington, DC 20005, Attention: Christina M. Gattuso, Esq.; and if to
the Company shall be delivered or sent by mail or facsimile to Carver Bancorp, Inc., 75 West 125th Street, New York, NY
10027, Attention: Michael T. Pugh, President & Chief Executive Officer, with a copy to Luse Gorman, PC, 5335 Wisconsin Avenue,
N.W., Suite 780, Washington, DC 20015, Attention: Marc Levy, Esq. Any such statements, requests, notices or agreements shall take
effect upon receipt thereof.

 

SECTION 13. BINDING
AGREEMENT. This Agreement shall be binding upon, and inure solely to the benefit of, the Agent and the Company, and, to the extent
provided in Section 8 hereof, the officers and directors of the Company and each person who controls the Company or the Agent,
and their respective heirs, executors, administrators, successors and assigns, and no other person shall acquire or have any right under
or by virtue of this Agreement. No purchaser of any of the Shares from the Agent shall be deemed a successor or assign by reason merely
of such purchase.

 

SECTION 14. TIME OF
THE ESSENCE. Time shall be of the essence of this Agreement. As used herein, the term “business day” shall mean
any day when the Commission’s office in Washington, D.C. is open for business.

 

SECTION 15. GOVERNING LAW;
CONSENT TO JURISDICTION; WAIVER OF IMMUNITY .THIS AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF
THE STATE OF NEW YORK, WITHOUT REGARD TO CONFLICT OF LAWS PRINCIPLES OF SAID STATE OTHER THAN SECTION 5-1401 OF THE NEW YORK GENERAL OBLIGATIONS
LAW.

 

    31

     

    

 

THE COMPANY, ON BEHALF
OF ITSELF AND ITS SUBSIDIARIES, HEREBY IRREVOCABLY SUBMITS TO THE EXCLUSIVE JURISDICTION OF THE FEDERAL AND NEW YORK STATE COURTS
LOCATED IN THE CITY OF NEW YORK IN CONNECTION WITH ANY SUIT, ACTION OR PROCEEDING RELATED TO THIS AGREEMENT OR ANY OF THE MATTERS
CONTEMPLATED HEREBY, IRREVOCABLY WAIVES ANY DEFENSE OF LACK OF PERSONAL JURISDICTION AND IRREVOCABLY AGREES THAT ALL CLAIMS IN
RESPECT OF ANY SUIT, ACTION OR PROCEEDING MAY BE HEARD AND DETERMINED IN ANY SUCH COURT. THE COMPANY, ON BEHALF OF ITSELF AND ITS
SUBSIDIARIES, IRREVOCABLY WAIVES, TO THE FULLEST EXTENT IT MAY EFFECTIVELY DO SO UNDER APPLICABLE LAW, ANY OBJECTION WHICH IT MAY
NOW OR HEREAFTER HAVE TO THE LAYING OF VENUE OF ANY SUCH SUIT, ACTION OR PROCEEDING BROUGHT IN ANY SUCH COURT AND ANY CLAIM THAT ANY
SUCH SUIT, ACTION OR PROCEEDING BROUGHT IN ANY SUCH COURT HAS BEEN BROUGHT IN AN INCONVENIENT FORUM.

 

SECTION 16. COUNTERPARTS.
This Agreement may be executed by any one or more of the parties hereto in any number of counterparts, each of which shall be deemed
to be an original, but all such counterparts shall together constitute one and the same instrument. Any facsimile or electronically
transmitted copies hereof or signatures hereon shall, for all purposes, be deemed originals.

 

SECTION 17. AMENDMENTS;
WAIVERS. No amendment or waiver of any provision of this Agreement, nor any consent or approval to any departure therefrom, shall
in any event be effective unless the same shall be in writing and signed by the parties hereto.

 

SECTION 18. SECTIONS.
The invalidity or unenforceability of any Section, paragraph or provision of this Agreement shall not affect the validity or
enforceability of any other Section, paragraph or provision hereof. If any Section, paragraph or provision of this Agreement is for
any reason determined to be invalid or unenforceable, there shall be deemed to be made such minor changes (and only such minor
changes) as are necessary to make it valid and enforceable.

 

SECTION 19. SUPERSEDES
PRIOR AGREEMENTS. This Agreement supersedes all prior agreements and understandings (whether written or oral) between the
Company, the Bank and the Agent, or any of them, with respect to the subject matter hereof.

 

[Signatures on Next Page]

 

    32

     

    

 

If the foregoing is in accordance
with your understanding, please sign and return to us four counterparts hereof, and upon the acceptance hereof by you, this letter and
such acceptance hereof shall constitute a binding agreement between the Agent, the Bank and the Company.

 

	 	Very
    truly yours,
	 	 
	 	CARVER
    BANCORP, INC.
	 	 
	 	By:	/s/ Michael T. Pugh
	 	 	Michael T. Pugh
	 	 	President and Chief Executive Officer

 

	 	CARVER FEDERAL SAVINGS BANK
	 	 
	 	By:	/s/
Michael T. Pugh
	 	 	Michael T. Pugh
	 	 	President and Chief Executive Officer

 

	Accepted as of the date hereof:	 
	 	 
	PIPER SANDLER & CO.	 
	 	 
	 	 
	By:	Piper Sandler & Co.,

    the sole general partner	 
	 	 
	By:	/s/ Jennifer Docherty 	 
	 	Name: Jennifer Docherty	 
	 	Title: Managing Director	 

 

Signature Page to Sales Agency Agreement 

 

    33

     

    

 

SCHEDULE I

 

Placement Notice Information

 

Company Representatives

 

Michael T. Pugh

 

Christina Maier

 

Isaac Torres

  

Agent Representatives

 

Robert A. Kleinert

 

Steve McAuley

 

Attention Syndicate Desk

 

     

     

    

 

Schedule II 

List of Subsidiaries 

 

	 	 	 	 	 
	
    Banking Subsidiary
	  	Jurisdiction of Organization	 
	
    Carver Federal Savings Bank
	  	 	U.S.	  
	 	 
	
    Nonbanking Subsidiary
	  	Jurisdiction of

Organization	 
	Carver Statutory Trust I	  	 	Delaware	  
	CSFB Credit Corp.	  	 	New York	  
	CSFB Realty Corp.	  	 	New York	  
	Carver Asset Corp.	  	 	Delaware	  
	Carver Community Development Corporation	 	 	Delaware	 
	Sub CDE 1, LLC	 	 	Delaware	 
	Alhambra Holdings Corp.	 	 	Delaware	 

 

     

     

    

 

ANNEX I

 

Form of Placement Notice

 

[·],
2021

 

From:    Carver
Bancorp, Inc.

Attention: Michael T. Pugh

President and Chief Executive Officer

75 West 125th Street

New York, NY 14569

 

 

To:        Piper
Sandler & Co.

Attention: Syndicate Desk

1251 Avenue of the Americas, 6th Floor

New York, New York 10020

 

Subject:  Placement Notice

 

Ladies and Gentlemen:

 

Pursuant to the terms and
subject to the conditions contained in the Sales Agreement between Carver Bancorp, Inc. (the “Company”), and
Piper Sandler & Co.. (the “Agent”) dated December [·], 2021 (the
 “Agreement”), I, Michel T. Pugh, President and Chief Executive Officer of the Company, hereby request on
behalf of the Company that the Agent sell up to the lesser of shares of the Company’s common stock, $ .01 par value per share (the
 “Common Stock”) having an aggregate gross sales price of up to $[ ], in accordance with the following instructions,
if any:

 

	First date on which Shares may be sold:	[·], 2021
	 	 
	Last date on which Shares may be sold:	[Insert first date of next blackout period]
	 	 
	Dates on which Shares may not be sold:	N/A
	 	 
	Maximum number of Shares to be sold per Trading Day:	N/A

 

Capitalized terms defined in the Agreement shall
have the same meanings when used herein.

 

ADDITIONAL SALES PARAMETERS MAY BE ADDED,
SUCH AS THE MANNER IN WHICH SALES ARE TO BE MADE BY THE AGENT.

 

[Signature Page Follows]

 

     

     

    

 

	 	CARVER BANCORP, INC.
	 	 
	 	By:	  
	 	 	Michael T. Pugh
	 	 	President and Chief Executive Officer
	 	

 

	Accepted as of the date hereof:	 
	 	 
	PIPER SANDLER & CO.	 
	 	 
	By:	Piper Sandler & Co.., the sole
    general partner	 
	 	 
	By:	 	 
	 	Name:	 
	 	Title:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00337-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00337-of-00352.parquet"}]]